EurekaMag Full Text Articles Chapter 48,419

Straif, K.; Baan, R.; Cogliano, V. 2006: Butadiene or styrene or butadiene and styrene or else?. Occupational and Environmental Medicine 63(3): 157-158

Tsareva, A.P. 1956: Butadiene therapy in rheumatic and nonspecific and rheumatoid polyarthritis. Terapevticheskii Arkhiv 28(5): 14-23

Osipian, V.T.; Kazhdan, V.B.; Dunaeva, I.D. 1960: Butadion - an effective agent for the control of body lice. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 31: 18-22

Beklemishev, N.D. 1959: Butadion; review of the literature. Klinicheskaia Meditsina 37(3): 18-26

Sharanov, I.M. 1955: Butadione. Meditsinskaia Promyshlennost' SSSR 2: 46

Harris, D.; Mirza, Z. 2005: Butane encephalopathy. Emergency Medicine Journal: Emj 22(9): 676-677

Rodier, J. 1956: Butane heating apparatus and carbon monoxide poisoning. Maroc Medical 35(375): 792-793

Hirt, M.; Brzobohatá, A.; Dvorácek, I.; Stanková, M. 2004: Butane intoxication--three case reports. Soudni Lekarstvi 49(4): 54-56

Ritchie, L.K.; Harrison, W.T.A. 2004: Butane-1,4-diamine zinc(II) hydrogen phosphite. Acta Crystallographica. Section C Crystal Structure Communications 60(Part 12): M634-M636

Urpí, L.; Martínez-Palau, M.; Font-Bardia, M.è; Puiggalí, J. 2004: Butane-1,4-diyl bis(chloroacetate). Acta Crystallographica. Section C Crystal Structure Communications 60(Part 12): O847-O849

Ohta, E.; Higuchi, H.; Kawai, H.; Fujiwara, K.; Suzuki, T. 2005: Butane-1,4-diyl dications stabilized by steric factors: electrochiroptical response systems based on reversible interconversion between dihydro[5]helicene-type electron acceptors and electron-donating 1,1'-binaphthyls. Organic and Biomolecular Chemistry 3(16): 3024-3031

Lin, Y.L.; Blaschek, H.P. 1983: Butanol Production by a Butanol-Tolerant Strain of Clostridium acetobutylicum in Extruded Corn Broth. Applied and Environmental Microbiology 45(3): 966-973

Kotzaurek, R. 1960: Butanol extraction as a supplement to the Spitzy, Reese and Skrube methods of iodine determination. Klinische Wochenschrift 38: 995-997

Ezeji, T.C.; Qureshi, N.; Blaschek, H.P. 2004: Butanol fermentation research: upstream and downstream manipulations. Chemical Record 4(5): 305-314

Hiu, S.F.; Zhu, C.X.; Yan, R.T.; Chen, J.S. 1987: Butanol-Ethanol Dehydrogenase and Butanol-Ethanol-Isopropanol Dehydrogenase: Different Alcohol Dehydrogenases in two Strains of Clostridium beijerinckii (Clostridium butylicum). Applied and Environmental Microbiology 53(4): 697-703

Silver, H.K. 1958: Butanol-extractable iodine values in the offspring of diabetic women. A.M.A. Journal of Diseases of Children 96(2): 144-147

Lecomte, J.; Lapiere, C.M. 1960: Butanolamide of 1-methyl-D-lysergic acid and histamine liberation. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 154: 2386-2389

Jarowski, P.D.; Diederich, F.; Houk, K.N. 2006: Butatrienes as extended alkenes: barriers to internal rotation and substitution effects on the stabilities of the ground states and transition states. Journal of Physical Chemistry. a 110(22): 7237-7246

Jespersen, K. 1954: Butazolidin. Ugeskrift for Laeger 116(22): 846-848

Sigg, K. 1959: Butazolidin and compression therapy of thrombosis. Praxis 48(16): 389-393

Seidenschnur, G.; Niesert, W. 1958: Butazolidin (butalidon) in phlebitis. Zeitschrift für Arztliche Fortbildung 52(19): 815-817

Richter, R.; Schoberth, H. 1960: Butazolidin and delta-butazolidin in ambulatory orthopedic practice. Die Medizinische Welt 47: 2512-2515

Aeppli, H.; Rageth, S. 1957: Butazolidin as an additional factor in prevention of thromboembolism. Schweizerische Medizinische Wochenschrift 87(Suppl. 24): 751-755

Bobek, K.; Cepelak, V. 1958: Butazolidin as an antithrombotic agent. Gynaecologia. International Monthly Review of Obstetrics and Gynecology. Revue Internationale Mensuelle d'Obstetrique et de Gynecologie. Monatsschrift für Geburtshilfe und Gynakologie 145(6): 434-444

Bucher, H. 1954: Butazolidin in diabetes insipidus. Schweizerische Medizinische Wochenschrift 84(31): 910-911

Uher, M. 1957: Butazolidin in orthopedics. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 24(5): 391-394

Rossert, A. 1959: Butazolidin in otorhinolaryngology. Gazette Medicale de France 66(14): 1217-1220 Passim

Goldfain, E. 1953: Butazolidin in rheumatic diseases. Journal of the Oklahoma State Medical Association 46(2): 27-28

Smith, C.H.; Kunz, H.G. 1952: Butazolidin in rheumatoid disorders; a preliminary report. Journal of the Medical Society of New Jersey 49(7): 306-309

Robecchi, A.; Cartesegna, F.; Daneo, V. 1954: Butazolidin in rheumatologic therapy. Reumatismo 6(2 Suppl): 85-86

Ablard, G.; Larcan, A.; Welfringer, A. 1957: Butazolidin in the treatment of Bouillaud disease. L'Union Medicale du Canada 86(9): 932-940

Strazza, J.A.; Ressetar, M. 1953: Butazolidin in the treatment of arthritis; clinical studies with phenylbutazone. Journal of the Medical Society of New Jersey 50(8): 333-342

Steinbrocker, O.; Neustadt, D.H.; Ehrlich, M. 1954: Butazolidin in the treatment of gout with a comparison with other agents. Medical Clinics of North America 11: 611-624

Mccormick, E.W. 1956: Butazolidin in the treatment of non-articular rheumatic disorders. Acta Rheumatologica Scandinavica 2(2): 117-123

Schaal, W. 1953: Butazolidin in the treatment of painful arthropathies. Die Medizinische 44: 1432-1434

Viani, H. 1955: Butazolidin in the treatment of psoriasis. Journal of the Irish Medical Association 37(221): 345-347

Denck, H.; Salzmann, F. 1957: Butazolidin in the treatment of thrombophlebitis. Klinische Medizin; Osterreichische Zeitschrift für Wissenschaftliche und Praktische Medizin 12(8): 338-340

Tedeschi, G. 1953: Butazolidin in therapeutics. Acta Medica Italica di Malattie Infettive E Parassitarie 8(8): 210-215

Olkowski, L. 1961: Butazolidin in thrombophlebitis. Polski Przeglad Chirurgiczny 33: 461-465

Baerlocher, W. 1957: Butazolidin prevention of postoperative thromboembolism with special consideration of urological cases. Schweizerische Medizinische Wochenschrift 87(Suppl. 24): 750-751

Hornemann, M. 1960: Butazolidin therapy of thrombophlebitis from a dermatological point of view. Dermatologische Wochenschrift 141: 358-361

Koster, H.J. 1957: Butazolidin therapy of thrombosis. Zentralblatt für Gynakologie 79(26): 1009-1020

Lamache, A.; Bourel, M.; Delahaye 1956: Butazolidin, sedimentation rate and electrophoresis of proteins. Rhumatologie 5: 223

Bierstedt, P. 1954: Butazolidin-dipyrin preparations in treatment of phlebitis. Zeitschrift für Arztliche Fortbildung 48(23-24): 822-823

Littler, T.R. 1953: Polyarthritis with pulmonary manifestations. Rheumatism 9(2): 24-33

Felgenhauer, U.; Felgenhauer, W. 1965: Butazolidine Treatment of Adnexitis. Deutsches Medizinisches Journal 16: 196-198

Medrea, B.; Popescu, C.; Schwartz, M. 1960: Butazolidine and infectious mononucleosis. La Presse Medicale 68: 1784

Aleman, S. 1958: Butazolidine as an analgesic in malignant diseases. Svenska Lakartidningen 55(35): 2398 Passim

Bobek, K.; Cepelak, V. 1957: Butazolidine as an anticoagulant in the treatment of thrombosis. Casopis Lekaru Ceskych 96(19): 582-586

Belart, W. 1953: Butazolidine as antirheumatic and its comparison with irgapyrin. Deutsche Medizinische Wochenschrift 78(4): 129-131

Hartig, H. 1955: Butazolidine in infectious mononucleosis. Medizinische Klinik 50(46): 1950-1951

De Seze, S.; Levernieux, J. 1953: Butazolidine in rheumatic diseases. Revue du Rhumatisme et des Maladies Osteo-Articulaires 20(1): 6-13

Hubmann, H. 1956: Butazolidine in the orthopedic consultation hour. Medizinische Klinik 51(8): 304-311

Ablard, G.; Dry, J.; Larcan, A. 1956: Butazolidine in the treatment of acute articular rheumatism. Rhumatologie 3: 105-107

Paczynski, Z.A.; Paczynska, D.; Wlodarczyk, J. 1962: Butazolidine in the treatment of malignant granuloma. Polskie Archiwum Medycyny Wewnetrznej 32: 75-80

Lucherini, T.; Cecchi, E. 1953: Butazolidine in the treatment of rheumatism; preliminary note. Minerva Medica 44(10): 267-271

Salleras, V.; Ruz, F. 1956: Butazolidine in the treatment of superficial and deep phlebitis. Angiologia 8(4): 164-169

Von Rechenberg, H.K. 1953: Butazolidine in therapy of rheumatic diseases; clinical tests with 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine-sodium, a new pyrazol derivative. Schweizerische Medizinische Wochenschrift 83(7): 159-164

Castagna, R.; Mairano, C. 1957: Butazolidine in therapy of thrombophlebitis. Minerva Medica 48(93): 3915-3917

Pulver, R. 1954: Butazolidine inhibition of the enzymatic decomposition of drugs. Archives Internationales de Pharmacodynamie et de Therapie 98(4): 437-442

Juul-Moller, O. 1960: Butazolidine therapy in medical practice. Ugeskrift for Laeger 122: 957-965

Wengraf, G. 1954: Butazolidine therapy of blood diseases. Wiener Medizinische Wochenschrift 104(51-52): 1031

Huber, K.; Binswanger, D. 1953: Butazolidine therapy of rheumatic diseases. Schweizerische Medizinische Wochenschrift 83(21): 496-498

Kirchmair, H.; Aselmann, G. 1959: Butazolidine therapy of rheumatic fever in children. Medizinische Monatsschrift 13(5): 272-275

Meyer, M.P. 1955: Butazolidine therapy of rheumatoid arthritis and Bechterew's disease. Nederlands Tijdschrift Voor Geneeskunde 99(22): 1546-1553

Egelius, N.; Nystrom, G. 1954: Butazolidine therapy of rheumatological diseases. Svenska Lakartidningen 51(12): 720-728

Martorell, F. 1956: Butazolidine therapy of thrombophlebitis. Angiologia 8(3): 124-125

Dudik, E. 1953: Butazolidine treatment of two cases of polyradiculitis serosa (Guillain-Barré). Therapie der Gegenwart 92(6): 229-230

Pawelec, W.; Lenkowski, P. 1953: Butazolidine, a new preparation prepared in Poland in treatment of rheumatism. Polski Tygodnik Lekarski 8(13): 503-504

Lovgren, O. 1957: Butazolidine, an antirheumatic agent. Svenska Lakartidningen 54(13): 959-963

Malm, A.; Holen, O. 1964: Butazolidine-Tanderil Treatment in Thoracic Surgery. Svenska Lakartidningen 61: 3321-3328

Bylka, W.ła.; Kornobis, J. 2005: Butcher's Broom, in the treatment of venous insufficiency. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(110): 234-236

Adrio, J.; Carretero, J.C. 2007: Butenolide synthesis by molybdenum-mediated hetero-pauson-khand reaction of alkynyl aldehydes. Journal of the American Chemical Society 129(4): 778-779

Schumann, H.; Schutte, S.; Kroth, H.-J.ür.; Lentz, D. 2004: Butenyl-substituted alkaline-earth metallocenes: a first step towards olefin complexes of the alkaline-earth metals. Angewandte Chemie 43(45): 6208-6211

McHugh, P.; Aitcheson, F.; Duncan, B.; Houghton, F. 2003: Buteyko Breathing Technique for asthma: an effective intervention. New Zealand Medical Journal 116(1187): U710

McHugh, P.; Duncan, B.; Houghton, F. 2006: Buteyko breathing technique and asthma in children: a case series. New Zealand Medical Journal 119(1234): U1988

Holt, S.; Beasley, R. 2004: Buteyko pseudoscience. New Zealand Medical Journal 117(1188): U754

McHugh, P.; Aitcheson, F.; Duncan, B.; Houghton, F. 2004: Buteyko: an effective complementary therapy. New Zealand Medical Journal 117(1189): U781

Keeri-Szanto, M.; Labarre, J. 1957: Buthalitone sodium anaesthesia: drug consumption and serum protein studies. Canadian Anaesthetists' Society Journal 4(3): 338-344

Henderson, A.G.; Mackett, J. 1957: Buthalitone sodium in out-patient anaesthesia. British Medical Journal 1(5027): 1095-1097

Young, D.S. 1956: Buthalitone sodium, nitrous oxide and oxygen in a series of one hundred dental cases. Proceedings of the Royal Society of Medicine 49(10): 735-736

Kane, P.O.; Stephens, C.J. 1959: Buthalitone sodium. its effect on the foetus and its rate of passage across the human placenta. British Journal of Anaesthesia 31: 533-537

Heifetz, C.L.; Chodubski, J.A.; Pearson, I.A.; Silverman, C.A.; Fisher, M.W. 1974: Butirosin compared with gentamicin in vitro and in vivo. Antimicrobial Agents and ChemoTherapy 6(2): 124-135

Hyde, R.W. 1959: Butler Health Center; first full year of operation. Rhode Island Medical Journal 42: 515-519 Passim

Hyde, R.W. 1958: Butler Health Center; today. Rhode Island Medical Journal 41(5): 261-263

Rosselle, N.; De Doncker, K.; Van Betsbrugge, A. 1959: Butobarbital-camphor combination in chronaximetric examinations in children. Bruxelles Medical 39: 1015-1017

Dawn, A.G.; Yosipovitch, G. 2006: Butorphanol for treatment of intractable pruritus. Journal of the American Academy of Dermatology 54(3): 527-531

Kuriakose, R.; Balakrishnan, M. 2007: Butorphanol tartarate in sick sinus syndrome. Journal of Clinical Anesthesia 19(1): 78

Chapman, S. 2006: Butt clean up campaigns: wolves in sheep's clothing?. Tobacco Control 15(4): 273

Turner, K.M.; Gordon, J. 2004: Butt in, butt out: pupils' views on the extent to which staff could and should enforce smoking restrictions. Health Education Research 19(1): 40-50

Sullivan, P.; Wharry, S. 2004: Butt out or lose our business, CMA tells cities. Cmaj: Canadian Medical Association Journal 170(7): 1189-1190

Gosset, J. 1955: Butt-strap graft (edgewise inlay) in low pseudarthrosis of tibia. Memoires. Academie de Chirurgie 81(20-21): 584-585

Klamerth, O. 1953: Butter yellow under the influence of yeasts. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 292(3-5): 170-173

Takaki, K.; Ono, Y. 1951: Butter yellow; effect of butter yellow feeding on rat liver cells Japanese text. Gan 42(2-4): 221-222

Sharp, D. 2004: Butter-fingers. Lancet 363(9408): 506

Giles, M.; Ulbricht, C.; Khalsa, K.P.S.; Kirkwood, C.D.; Park, C.; Basch, E. 2005: Butterbur: an evidence-based systematic review by the natural standard research collaboration. Journal of Herbal PharmacoTherapy 5(3): 119-143

Vieco Roldan, C. 1959: Butterfat and extraneous fats. Revista de Sanidad E Higiene Publica 33: 498-500

Supple, L.K. 1964: Butterfield Memorial Hospital. New York State Journal of Medicine 64: 1639-1641

Bächer, C.; Kihm, A.; Schrack, L.; Kaestner, L.; Laschke, M.W.; Wagner, C.; Gekle, S. 2018: Antimargination of Microparticles and Platelets in the Vicinity of Branching Vessels. Biophysical Journal 115(2): 411-425

Gerber, W.E. 1964: Butterfly Appliance: new Approach to Maxillary Dental Arch Expansion. Journal of the American Dental Association 69: 287-290

Palaudoux, J.; Hochlaf, M. 2007: Butterfly C2H2++: new way for the decomposition of the acetylene dication. Journal of chemical physics 126(4): 044302

Ghanem, M.A.; Monroy, A.; Alizade, F.S.; Nicolau, Y.; Eavey, R.D. 2006: Butterfly cartilage graft inlay tympanoplasty for large perforations. Laryngoscope 116(10): 1813-1816

Silaghi-Dumitrescu, I.; Bitterwolf, T.E.; King, R.B. 2006: Butterfly diradical intermediates in photochemical reactions of Fe2(CO)6(mu-S2). Journal of the American Chemical Society 128(16): 5342-5343

Zwinggi, S.; Schelling, H.-R. 2006: Need for safety and security. KRANKENPFLEGE. Soins Infirmiers 99(11): 30

Cave, P. 1958: Butterfly vertebra. British Journal of Radiology 31(369): 503-506

Lozina-Lozinskii, L.K. 1953: Butterfly wing as receptor of infrared radiation. Doklady Akademii Nauk SSSR 93(2): 369-372

Stavenga, D.G.; Stowe, S.; Siebke, K.; Zeil, J.; Arikawa, K. 2004: Butterfly wing colours: scale beads make white pierid wings brighter. Proceedings. Biological Sciences 271(1548): 1577-1584

Magrisso, R.M. 2006: Butterfly woman. Patient Education and Counseling 64(1-3): 3-5

Lorber, J. 1962: Butterfly' lateral ventricles associated with large head, fits and mental retardation. a new syndrome?. Proceedings of the Royal Society of Medicine 55: 235-236

Gundes, H.; Tosun, B.; Buluc, L.; Alici, T. 2006: Butterfly-type splint immobilization to prevent thenar flap detachment in children. Orthopedics 29(6): 495-496

Shafer, R.W. 2006: Butting heads with resistance. Iapac Monthly 12(6): 180-189

Mackay, B. 2004: Butting out in Canada: five down, eight to go. Cmaj: Canadian Medical Association Journal 171(6): 558

Dakdouk, G.K.; Araj, G.F.; Awar, G.N. 2002: Buttock abscess brucellosis. Scandinavian Journal of Infectious Diseases 34(12): 934-936

Murillo, W.L. 2004: Buttock augmentation: case studies of fat injection monitored by magnetic resonance imaging. Plastic and Reconstructive Surgery 114(6): 1606

Benito-Ruiz, J.ús. 2003: Buttock implants for male chest enhancement. Plastic and Reconstructive Surgery 112(7): 1951

Rodero, L.; Canga, A.; Figols, J.; Berciano, J.; Combarros, O. 2004: Buttock mass and malignant sciatic nerve tumor. Neurologia 19(1): 27-31

Mounasamy, V.; Thacker, M.M.; Humble, S.; Scully, S.P.; Temple, H.T. 2006: Buttock mass in a 37-year-old woman. Clinical Orthopaedics and Related Research 446: 291-296

Dietz, D.M.; Stahlfeld, K.R.; Bansal, S.K.; Christopherson, W.A. 2004: Buttock necrosis after uterine artery embolization. Obstetrics and Gynecology 104(5 Part 2): 1159-1161

Behranwala, K.A.; Barry, P.; A'Hern, R.; Thomas, J.M. 2003: Buttock soft tissue sarcoma: clinical features, treatment, and prognosis. Annals of Surgical Oncology 10(8): 961-971

Ryan, P. 2006: Buttock spots. Clinical Pediatrics 45(9): 867-869

Larrégue, M.; Vabres, P. 2002: Buttocks dermatitis in infants. Servir 50(6): 301-306

Gonzalez, R. 2006: Buttocks lifting: how and when to use medial, lateral, lower, and upper lifting techniques. Clinics in Plastic Surgery 33(3): 467-478

Bartlett, D. 2006: Button battery ingestions in children. Journal of Emergency Nursing 32(2): 189-190

Dorton, H.E. 1954: Button hole incision in perforated duodenal ulcer. Journal of the Kentucky State Medical Association 52(6): 436; Passim

Rossi, A.M.; Solomon, P. 1964: Button-Pressing for a Time-Off Reward During Sensory Deprivation. I. Relation to Activity Reward. Ii. Relation to Descriptions of Experience. Perceptual and Motor Skills 18: 211-216

Rossi, A.M.; Solomon, P. 1964: Button-Pressing for a Time-Off Reward during Sensory Deprivation. Iii. Effects of Varied Time-Off Rewards. Perceptual and Motor Skills 18: 794-796

Rossi, A.M.; Solomon, P. 1964: Button-Pressing for a Time-Off Reward During Sensory Deprivation. V. Effects of Relatively Comfortable and Uncomfortable Sessions. Perceptual and Motor Skills 19: 803-807

Rossi, A.M.; Solomon, P. 1964: Button-Pressing for Time-Off Reward during Sensory Deprivation. Iv. Relation to Change in Ratings of Well-Being. Perceptual and Motor Skills 19: 520-522

Bruner, J.M. 1950: Buttonhook retractor for hand surgery. Journal of Bone and Joint Surgery. American Volume 32-A(3): 698

Gorecka, J.; Heiss, C.; Scopelliti, R.; Schlosser, M. 2004: Buttressing effects on haloarene deprotonation: a merely kinetic or also thermodynamic phenomenon?. Organic Letters 6(24): 4591-4593

Yo, L.S.F.; Consten, E.C.J.; Quarles van Ufford, H.M.E.; Gooszen, H.G.; Gagner, M. 2006: Buttressing of the staple line in gastrointestinal anastomoses: overview of new technology designed to reduce perioperative complications. Digestive Surgery 23(5-6): 283-291

Sen, S.; Zachariah, N.; Chacko, J.; Thomas, G. 2003: Buttressing the divided bladder neck by a rectus abdominis muscle flap to prevent urethral recanalisation in paediatric urinary incontinence. Pediatric Surgery International 19(1-2): 124-126

Liberatore, A-Marie.; Schulz, J.; Favre-Guilmard, C.; Pommier, J.; Lannoy, J.; Pawlowski, E.; Barthelemy, M-Anne.; Huchet, M.; Auguet, M.; Chabrier, P-Etienne.; Bigg, D. 2007: Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain. Bioorganic and Medicinal Chemistry Letters 17(6): 1746-1749

Sondergeld, L.J.; Bush, M.E.; Bellinger, A.; Bushey, M.M. 2003: Butyl acrylate porous polymer monoliths in fused-silica capillaries for use in capillary electrochromatography. Journal of Chromatography. a 1004(1-2): 155-165

Lozada, B.B.; Kertesz, I.; Furman, B.; Del Castillo, C.M.; Diez, E.; Ferrando, H. 1962: Butyl-sympathol in the treatment of peripheral vascular diseases. La Semana Medica 121: 384-391

Williams, G.M. 2003: Butylated hydroxytoluene (BHT) at 1000 and 4000 ppm in the diet protected turkeys against aflatoxicosis. Toxicology and Applied Pharmacology 189(2): 151; Author Reply 152

Grillo, C.A.; Dulout, F.N. 2006: Butylated hydroxytoluene does not protect Chinese hamster ovary cells from chromosomal damage induced by high-dose rate 192Ir irradiation. Mutagenesis 21(6): 405-410

Sannazzari, P.; Gay, A.; Assereto, G. 1957: Butylogram. II. Behavior of urinary gluco- and sulfo- conjugated steroids in liver disease, basal conditions and after cortisone load. Archivio "e. Maragliano" di Patologia E Clinica 13(6): 1549-1553

Baumgarten, K.; Hofhansl, W. 1958: Butylon in inflammatory disorders of the adnexa. Wiener Medizinische Wochenschrift 108(44): 913-914

Wasilewski, A. 1960: Butylon in pancreatitis and subcutaneous necrosis. Wiener Medizinische Wochenschrift 110: 57-59

Rumiantsev, V.I.; Ezhov, V.A.; Boriskova, P.I.; Politseeva, Z.P. 1964: Butylpyridine Bromide Desemulgator for the Extraction of Penicillin. Meditsinskaia Promyshlennost' SSSR 18: 36-38

Hulek, M.; Kos, M. 1955: Butylpyrin in clinical gynecological practice; a contribution to the therapy of gynecological inflammations. Casopis Lekaru Ceskych 94(30-31): 813-815

Stepanek, K.; Rydvalova, A. 1953: Butylpyrine in clinical and ambulatory practice. Casopis Lekaru Ceskych 92(41-42): 1151-1154

Odvarkova, J. 1956: Butylpyrine poisoning in a 15-month-old infant. Ceskoslovenska Pediatrie 11(7): 535-537

Grabowski, K. 1964: Butylrylperazine in the Treatment of Chronic Schizophrenia. Neurologia Neurochirurgia i Psychiatria Polska 14: 327-331

Vedoya, R.; Rodriguez, P.; Gaguine, S.; Fidelman, J.; Mendelzon, J.; Papakis, M.E. 1963: Butylsympathol in the treatment of arteriosclerosis obliterans of the lower extremities. La Semana Medica 122: 585-586

Delucchi, F.; Tombesi, N.B.; Freije, R.én.H.; Marcovecchio, J.E. 2007: Butyltin compounds in sediments of the Bahía Blanca estuary, Argentina. Environmental Monitoring and Assessment 132(1-3): 445-451

Brest, A.N.; Onesti, G.; Swartz, C.; Berliner, H.; Moyer, J.H. 1962: Butynamine hydrochloride as an antihypertensive agent. Current Therapeutic Research 4: 313-316

Weinberg, R.S.; Ji, X.; Sutton, M.; Perrine, S.; Galperin, Y.; Li, Q.; Liebhaber, S.A.; Stamatoyannopoulos, G.; Atweh, G.F. 2005: Butyrate increases the efficiency of translation of gamma-globin mRNA. Blood 105(4): 1807-1809

Zapolska-Downar, D.; Siennicka, A.; Kaczmarczyk, M.; Kołodziej, B.; Naruszewicz, M. 2004: Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. Journal of Nutritional Biochemistry 15(4): 220-228

Menzel, T.; Lührs, H.; Zirlik, S.; Schauber, J.ür.; Kudlich, T.; Gerke, T.; Gostner, A.; Neumann, M.; Melcher, R.; Scheppach, W. 2004: Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflammatory Bowel Diseases 10(2): 122-128

Farrow, B.; Rychahou, P.; O'Connor, K.L.; Evers, B.M. 2003: Butyrate inhibits pancreatic cancer invasion. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 7(7): 864-870

Xing, Y.; Liu, Z.; Wang, L.-H.; Huang, F.; Wang, H.-J.; Li, Z.-Z. 2006: Butyrate sensitizes the release of substance P and calcitonin gene-related peptide evoked by capsaicin from primary cultured rat dorsal root ganglion neurons. Neuro Endocrinology Letters 27(6): 695-701

Miki, K.; Unno, N.; Nagata, T.; Uchijima, M.; Konno, H.; Koide, Y.; Nakamura, S. 2004: Butyrate suppresses hypoxia-inducible factor-1 activity in intestinal epithelial cells under hypoxic conditions. Shock 22(5): 446-452

Kendall, M.M.; Liu, Y.; Boone, D.R. 2006: Butyrate- and propionate-degrading syntrophs from permanently cold marine sediments in Skan Bay, Alaska, and description of Algorimarina butyrica gen. nov., sp. nov. Fems Microbiology Letters 262(1): 107-114

Li, C.J.; Elsasser, T.H. 2005: Butyrate-induced apoptosis and cell cycle arrest in bovine kidney epithelial cells: involvement of caspase and proteasome pathways. Journal of Animal Science 83(1): 89-97

Karna, E.; Miltyk, W.; Pałka, J.A. 2006: Butyrate-induced collagen biosynthesis in cultured fibroblasts is independent on alpha2beta1 integrin signalling and undergoes through IGF-i receptor cascade. Molecular and Cellular Biochemistry 286(1-2): 147-152

Buckley, A.R.; Krumenacker, J.S.; Buckley, D.J.; Leff, M.A.; Magnuson, N.S.; Reed, J.C.; Miyashita, T.; de Jong, G.; Gout, P.W. 1997: Butyrate-induced reversal of dexamethasone resistance in autonomous rat Nb2 lymphoma cells. Apoptosis: An International Journal on Programmed Cell Death 2(6): 518-528

Tamura, T.; Tsuruta, N.; Hirano, K.; Yamaguchi, K.; Oda, T. 2003: Butyric acid sensitizes Vero cells to ricin-induced apoptosis via accelerated activation of multiple signal transduction pathways. Cell Structure and Function 28(5): 475-485

McSweeney, C.S.; Dulieu, A.; Bunch, R. 1998: Butyrivibrio spp. and other xylanolytic microorganisms from the rumen have cinnamoyl esterase activity. Anaerobe 4(1): 57-65

Pompei, A. 1963: Butyrrylperazine in Clinical Practice. Archivio "e. Maragliano" di Patologia e Clinica 19: 825-836

Kalow, W. 1952: Butyrylcholine esterase in the blood serum of man and animal. Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie 215(3-4): 370-377

Calderon-Margalit, R.; Adler, B.; Abramson, J.H.; Gofin, J.; Kark, J.D. 2006: Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem. Clinical Chemistry 52(5): 845-852

Lejus, C.; Delaroche, O.; Trille, E.; Blanloeil, Y.; Pinaud, M. 2006: Butyrylcholinesterase deficiency: how to analyse the cholinesterase activity in small children?. Annales Francaises d'Anesthesie et de Reanimation 25(6): 657-660

Graham, J.R.; Wright, B.S.; Rezk, P.E.; Gordon, R.K.; Sciuto, A.M.; Nambiar, M.P. 2006: Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX. Inhalation Toxicology 18(7): 493-500

Geula, C.; Darvesh, S. 2004: Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease. Drugs of Today 40(8): 711-721

Sirot'áková, M.ár.; Schmidtová, K.ín.; Kocisová, M. 2004: Butyrylcholinesterase-positive innervation of the spleen in rats. Acta Medica 47(3): 201-204

Nachon, F.; Nicolet, Y.; Masson, P. 2005: Butyrylcholinesterase: 3D structure, catalytic mechanisms. Annales Pharmaceutiques Francaises 63(3): 194-206

Greig, N.H.; Lahiri, D.K.; Sambamurti, K. 2002: Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics 14(Suppl 1): 77-91

Tasker, A.; Perry, E.K.; Ballard, C.G. 2005: Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment. Expert Review of Neurotherapeutics 5(1): 101-106

Caliceti, G.; Ceroni, T. 1963: Butyrylperazine in the Therapy of Vertigo. L'Oto-Rino-Laringologia Italiana 32: 86-94

Fearn, J.H. 1962: Buxton Spa. PhysioTherapy 48: 302-303

Lockwood, R.A. 1951: Buxton spa, Derbyshire. British Journal of Physical Medicine: Including its Application to Industry 14(11): 244-247

Kupchan, S.M.; Kurosawa, E. 1965: Buxus Alkaloids. 8. the Isolation and Constitution of Cycloprotobuxine-D. Journal of Organic Chemistry 30: 2046-2047

Boutaric, J.-J.é; Patin, G. 2003: Buy Patin. a physician in Moliere's time. La Revue du Praticien 53(11): 1269-1273

Gunzelman, P.L. 1955: Buy and buy. Hospital Progress 36(2): 55

Hervey, T.K. 1998: Buy baby: the European Union and regulation of human reproduction. Oxford Journal of Legal Studies 18(2): 207-233

Hicks, K.E.; Whittington, D. 2005: Buy/sell agreements in optometric practices. Optometry 76(12): 727-729

Simon, R.; Wilkinson, S. 2005: Buyer beware: practice value drops without team buy-in. Journal of the Massachusetts Dental Society 54(1): 18-20

Hubbard, K.L.; Zapf, P.A.; Ronan, K.A. 2003: Competency restoration: an examination of the differences between defendants predicted restorable and not restorable to competency. Law and Human Behavior 27(2): 127-139

Droppert, P.M. 1990: The effects of microgravity on the skeletal system--a review. Journal of the British Interplanetary Society 43(1): 19-24

Droppert, P.M. 1990: The effects of microgravity on the skeletal system--a review. Journal of the British Interplanetary Society 43(1): 19-24

Weinzettal, R.J. 1961: Buyer, pharmacist and salesman need to understand each other. Hospital Management 92: 36-39

Chen, L.; Ao, X.; Ren, Q.; Wang, Z.-N.; Lu, C.; Xu, Y.; Jiang, L.; Luo, Y.; Xu, H.-M.; Zhang, X. 2005: Linkage disequilibrium and haplotype analysis of two single nucleotide polymorphisms in STK15 in Chinese. Yi Chuan Xue Bao 32(4): 331-336

Wolfe, S.A. 2003: IAPAC, HIVMA collaborate on US HIV specialization. Iapac Monthly 9(11): 281

Foldy, S.L.; Barthell, E.; Silva, J.; Biedrzycki, P.; Howe, D.; Erme, M.; Keaton, B.; Hamilton, C.; Brewer, L.; Miller, G.; Eby, E.; Coles, R.; Pemble, K.; Felton, C. 2004: SARS Surveillance Project--Internet-enabled multiregion surveillance for rapidly emerging disease. Mmwr Supplements 53: 407-408

Freedman, G. 2006: Buyers' guide to LED curing lights. LED curing lights are basic tools of the profession. Dentistry Today 25(11): 150; 152-158

Freedman, G. 2006: Buyers' guide to air-driven handpieces. Handpieces play an important role in practices. Dentistry Today 25(11): 140; 142 144-148

Freedman, G. 2004: Buyers' guide to all-ceramic systems. Dentistry Today 23(10): 150

Freedman, G. 2006: Buyers' guide to all-ceramic systems. Restoring the appearance of the human tooth. Dentistry Today 25(11): 136; 138-139

Freedman, G. 2006: Buyers' guide to cosmetic imaging systems. Dentistry Today 25(5): 136-139

Freedman, G. 2003: Buyers' guide to curing lights. Dentistry Today 22(9): 140-142; 144-151

Freedman, G. 2003: Buyers' guide to curing lights. Dentistry Today 22(9): 140-142; 144-151

Freedman, G. 2005: Buyers' guide to diamonds and burs. So, what's new in burs?. Dentistry Today 24(10): 162-4 166 168-75

Freedman, G. 2006: Buyers' guide to digital cameras. Dentistry Today 25(5): 132-135

Freedman, G. 2006: Buyers' guide to digital radiography--intraoral. Dentistry Today 25(3): 132; 134

Freedman, G. 2004: Buyers' guide to impression materials. Dentistry Today 23(3): 136-143

Freedman, G. 2006: Buyers' guide to intraoral video cameras. Dentistry Today 25(5): 140; 142 144-150

Freedman, G.; Glassman, G. 2004: Buyers' guide to rotary and hand endodontic files. Dentistry Today 23(3): 144-146; 148-151

Freedman, G. 2005: Buyers guide to all-ceramic systems. Dentistry Today 24(10): 152; 154, 156

Freedman, G. 2003: Buyers' guide to shade-matching systems. Welcoming a new era of predictability. Dentistry Today 22(6): 128-130; 132

Rubas, W.L.; Callahan, J.M. 2003: Buyers--and sellers--beware. when facilities change hands, both buyers and sellers must protect their interests through a careful process of due diligence. Provider 29(3): 51

Autian, J. 1964: Buying Safe Plastic Devices for use in Patient Care. Hospitals 38: 104-109

Anonymous 1949: Buying Second Hand Books. Bulletin of the Medical Library Association 37(4): 365-366

Trappes-Lomax, T.; Ellis, A.; Fox, M.; Taylor, R.; Power, M.; Stead, J.; Bainbridge, I. 2006: Buying Time I: a prospective, controlled trial of a joint health/social care residential rehabilitation unit for older people on discharge from hospital. Health and Social Care in the Community 14(1): 49-62

Cole, R.E. 2004: Buying a densitometer. FAQs answered. Medical Economics 81(7): 60-64

Sorenson, S.B.; Vittes, K.A. 2003: Buying a handgun for someone else: firearm dealer willingness to sell. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 9(2): 147-150

Galloro, V. 2004: Buying a not-for-profit hospital. Slow and steady wins the race. Complementary missions can lead to matches made in healthcare heaven. Modern Healthcare 34(45): S14 S16

Quarnstrom, F. 2002: Buying a practice: the bottom line method of practice valuation. Dentistry Today 21(2): 142-147

Everson, F.P. 2003: Buying an LCD projector for emergency nursing continuing education: one ENA state council's experience. Journal of emergency nursing 29(2): 168-170

Willcox, S. 2005: Buying best value health care: Evolution of purchasing among Australian private health insurers. Australia and New Zealand Health Policy 2(1): 6

Richardson, L. 2004: Buying biosafety--is the price right?. New England Journal of Medicine 350(21): 2121-2123

Yang, B.; Lester, D. 2006: Buying books online: a replication. Perceptual and Motor Skills 102(1): 73-74

Yang, B.; Lester, D. 2003: Buying books online: follow-up. Psychological Reports 92(2): 393-394

Anonymous 2004: Buying charts. Mgma Connexion 4(8): 21-22

Page, L. 2005: Buying en masse. Hospitals unite for purchasing power. Materials Management in Health Care 14(6): 35-37

Dilks, S. 2006: Buying for results. Nursing Standard: 1987) 20(29): 70-71

Auslander, C.O. 1950: Buying for the hospital in an inflationary economy. Hospitals 24(11): 74-76

Scripter, L. 1959: Buying frozen foods. Hospital Progress 40: 84-86

Ortolon, K. 2003: Buying health care off the rack. Texas Medicine 99(5): 41-44

Gillespie, D. 2004: Buying health in Honduras. Lancet 364(9450): 1996-1997

Butcher, J. 2007: Buying in on the brain. Lancet 369(9561): 551

Siniawski, J. 2004: Buying into a lease plan. Materials Management in Health Care 13(3): 31-32

Paige, L. 2005: Buying into diversity. Materials Management in Health Care 14(8): 18-22

Romano, M. 2005: Buying into practices. Three hospitals announce deals covering 300 docs. Modern Healthcare 35(24): 4

Ankarberg, P. 2003: The best help for suicide-prone patients is psychotherapy--not antidepressive agents. Lakartidningen 100(50): 4222-4226

Mohr, O. 1956: Buying lab glassware. Hospital Management 82(2): 106-109

Pliler, R.G. 1956: Buying laboratory supplies requires three-way cooperation. Hospitals 30(22): 64; Passim

Anonymous 1951: Buying of small quantities of supplies by pharmacies. Farmaceutski Glasnik 7(1): 31-32

Macfarlane, F.O. 1961: Buying office supplies & equipment. Hospital Progress 42: 52-58

Yang, B.; Lester, D. 2004: Buying online: textbooks versus books. Psychological Reports 95(3 Pt 1): 878

Cohen, N.; de Cock Buning, T. 2003: Buying or making, what's it to be? The choice between acquiring or generating genetically modified animals or embryos in the light of the three Rs. Alternatives to Laboratory Animals: Atla 31(3): 289-294

Kramer, S. 2007: Buying power. The shift toward consumer-driven healthcare may bring about a fundamental shift in how providers ply their craft. Healthcare Informatics: the Business Magazine for Information and Communication Systems 24(1): 35-6 38

Anonymous 2003: Buying prescription drugs on the Internet. Awhonn Lifelines 7(1): 29-30

Johnson, B.I. 1950: Buying safety against operating room explosion hazards. Hospitals 24(12): 87-88

Yang, B.; Lester, D. 2002: Buying textbooks online. Psychological Reports 91(3 Pt 2): 1222-1224

Ellis, A.; Trappes-Lomax, T.; Fox, M.; Taylor, R.; Power, M.; Stead, J.; Bainbridge, I. 2006: Buying time II: an economic evaluation of a joint NHS/Social Services residential rehabilitation unit for older people on discharge from hospital. Health and Social Care in the Community 14(2): 95-106

Anonymous 2004: Buying time, saving lives: hospital rapid response teams find ways to reduce mortality outside the ICU. Quality Letter for Healthcare Leaders 16(12): 2-9 1

Jauhar, S. 2003: Buying time: doctors debate the ethics of care and cost. New York Times on the Web 2003: F5

Anonymous 1951: Buying vials for penicillin. Medika; Informativni Casopis Farmaceutiskih Poduzeca Nrh 4(1): 7

Orrie, P.; Fenton, J.C. 1965: Buzzer Ulcers. Proceedings of the Royal Society of Medicine 58: 623-624

Appaix, A.; Bouche, J.; Bremond, G. 1958: Buzzing in the ear. Revue de Laryngologie - Otologie - Rhinologie 79(1-2): 119; Discussion: 119-120

Cambrelin, G. 1957: Buzzing sound in ears and allergy. Les Annales d'Oto-Laryngologie 74(9): 713-714

Scott, J.Schulte. 2006: Buzzword of the year: "transparency". Healthcare Financial Management: Journal of the Healthcare Financial Management Association 60(7): 36-37

Lee, L.A. 2000: Buzzwords with a basis. Nursing Management 31(10): 24-27; Quiz: 27-28

Hirsch, E.F. 1961: Buzzy, the cat with lung flukes. a story to emphasize that golden opportunities lurk in the shadows about us. Illinois Medical Journal 119: 90-96

Boorman, K.E.; Zeitlin, R.A. 1964: Bv--A Sub-Group of B which Lacks Part of the Normal Human B Antigen. Vox Sanguinis 9: 278-288

Siniashina, L.N.; Vorontsov, V.V.; Semin, E.G.; Chestkov, A.V.; Tsygankov, I.D.; Karataev, G.I. 2005: Bvg-negative regulation of repeated sequence transferring in Bordetella pertussis cells. Genetika 41(12): 1608-1616

Williams, C.L.; Boucher, P.E.; Stibitz, S.; Cotter, P.A. 2005: BvgA functions as both an activator and a repressor to control Bvg phase expression of bipA in Bordetella pertussis. Molecular Microbiology 56(1): 175-188

Levine, P.; Celano, M.; Griset, T. 1958: Bw: a new allele of the ABO locus. Bibliotheca Haematologica 7: 132-135

Lengsfeld, W. 1951: Bx preparation (vitamin T) and its effect on dystrophy and on prematures. Münchener Medizinische Wochenschrift 93(33-34): 1661-1663

Alter, A.A.; Rosenfield, R.E. 1964: Bx, a Subtype of B. Blood 23: 600-604

Yokoyama, M.; Stacey, S.M.; Dunsford, I. 1957: Bx--a new sub-group of the blood group B. Vox Sanguinis 2(5): 348-356

Fredell, C.H.; Kazan, I.W.; Washburn, J.B. 1964: By a Dam Site. Journal of Trauma 4: 186-196

Scarlett, E.P. 1953: By Apollo. Canadian Medical Association Journal 69(3): 324-328

Grist, N.R.; Ross, C.A.; Bell, E.J.; Stott, E.J. 1964: By means of Nearly 5,000 Cases, a Panorama of the Situation of Children and Adults Afflicted with Cerebral Motor Disability. Semaine des Hopitaux: Informations 3: 7-9

Lister, J. 1964: By the London Post. Centenary Thoughts. New England Journal of Medicine 270: 1188-1190

Kong-Oo Goh; Swisher, S.N.; Troup, S.B. 1964: By these Presents .. Archives of Internal Medicine 114: 462-465

Anonymous 1916: By way of Answer. Bulletin of the Medical Library Association 6(2): 43-44

Johnson, K. 2004: By accident, Utah is proving an ideal genetic laboratory. New York Times on the Web 2004: A1 A13

Butler, D.L. 1962: By air, sea or land. Canadian Hospital 39: 58-59

Berger, S.A. 2007: By any other name: ambiguity in marketing proprietary anti-infective agents. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 44(1): 65-68

Morreim, E.H. 2004: By any other name: the many iterations of "patient advocate" in clinical research. Irb 26(6): 1-8

Stanley, K.J. 2004: By examining what is, we can determine what can be. Ons News 19(9): 15

Lansdowne, J.W. 1950: By guess or by guide. South Dakota Journal of Medicine and Pharmacy 3(12): 379-382

Anonymous 2006: By gum, it might be good for you. Recent studies show that gum chewing may speed recovery from bowel surgery. Harvard Health Letter 31(10): 5

Rowe, R.C. 2003: By gum--a buccal delivery system. Drug Discovery Today 8(14): 617-618

Westin, M.; Saltvedt, S.; Almström, H.; Grunewald, C.; Valentin, L. 2007: By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? a study of 16,260 fetuses derived from an unselected pregnant population. Ultrasound in Obstetrics and Gynecology: the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 29(2): 150-158

Pohl, U. 2005: By invitation only. Physiology 20: 368

Beahan, S. 2003: By line, by hour: keeping the transcription machine running. Journal of Ahima 74(2): 46; 48, 50

Tunstall-Pedoe, H.; Woodward, M. 2006: By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart 92(3): 307-310

Sharma, D.C. 2005: By order of the court: environmental cleanup in India. Environmental Health Perspectives 113(6): A394-A397

Moon, S. 2004: By popular demand. Quality focus, labor shortages drive pay, survey shows. Modern Healthcare 34(31): 26-29

Watson, E.H. 1953: By precept; a critical appraisal of medical teaching. Journal of Medical Education 28(5): 11-16

Weigel, L. 1956: By principle, radiography without preparation should precede opaque cholecystography, and opacification by intravenous route should precede surgical intervention. Journal de Radiologie d'Electrologie and Archives d'Electricite Medicale 37(5-6): 391-393

Wonnacott, C.E. 1957: By remodeling its obsolete elevator system, this Utah hospital gained new efficiency between floors. Hospitals 31(21): 70 Passim

Silverman, W.J. 1957: By remodeling operating rooms, this hospital gives more patients better, speedier care. Hospitals 31(20): 49-51

Gené Badia, J. 2005: By taking joint decisions, we will gain in effectiveness. Atencion Primaria 35(4): 175-177

Lister, J. 1959: By the London Post: migration of doctors; dangers of advertising; facts about sickness. New England Journal of Medicine 260(5): 234-235

Lister, J. 1959: By the London Post: the art of consultation, hula-hoop syndrome; a doctor's lament. New England Journal of Medicine 260(9): 434-435

Lister, J. 1953: By the London post: cost of prescribing; medical responsibility; men and mountains. New England Journal of Medicine 249(9): 369-370

Lister, J. 1955: By the London post: private medical practice; the clinical approach; lecture notes. New England Journal of Medicine 253(26): 1162-1163

Ruder, K. 2006: By the book. Keep careful records of your blood glucose checks. Diabetes Forecast 59(4): 69-70

Edsel, W.M. 2004: By the book. Lessons learned from developing a physician-owners' manual. Mgma Connexion 4(5): 40-42

Stone, T. 2003: By the buy. Health Service Journal 113(5847): 35

Fitzgerald, M.; Bonner, A. 2007: By the day nurses bank up in a casual pool!. International Journal of Nursing Studies 44(5): 653-654

Ruiz-Doblado, S.; Estepa-Zabala, B.én.; García-Solier, R. 2005: Multivariate analysis in suicide attempts: a useful tool for the clinician. International Journal of Social Psychiatry 51(2): 99-100

Ventevogel, P.; Azimi, S.; Jalal, S.; Kortmann, F. 2003: Mental health care reform in Afghanistan. Journal of Ayub Medical College Abbottabad: Jamc 14(4): 1-3

Loundon, N. 2003: Cochlear implants in children. La Revue du Praticien 53(3): 237-239

Burda, D. 2005: Doc-execs wielding power. Modern Healthcare 35(31): 32-33

Anonymous 2006: By the numbers. 20 largest healthcare executive search firms ranked by number of U.S. placements made for senior-level (senior VP and above) healthcare executives in 2005. Modern Healthcare 36(27): 32

Schulte, D.J. 2005: Producing medical records in litigation. Michigan Medicine 104(3): 7

Moon, S. 2004: By the numbers. 25 busiest community hospital emergency departments. Ranked by number of emergency room visits in 2002. Modern Healthcare 34(25): 32

Doyle, R. 2004: By the numbers. A surplus of women. Scientific American 290(4): 33

Anonymous 2006: By the numbers. An annual resource guide filled with the numbers, rankings and financial figures that shape healthcare. Modern Healthcare Suppl: 2 4 6 Passim

Moon, S. 2004: By the numbers. Busiest children's hospitals ranked by number of 2003 admissions. Modern Healthcare 34(51): 28

Anonymous 2004: By the numbers. Construction. Modern Healthcare Suppl: 54 56 58

Anonymous 2004: By the numbers. Drugs/medical technology. Modern healthcare Suppl: 48

Doyle, R. 2003: By the numbers. Fertility volatility. Fluctuating U.S. birth rates elude definitive explanation. Scientific American 289(3): 38

Anonymous 2005: By the numbers. HSAs gaining momentum, new study shows. Ahip Coverage 46(3): 16-17

Leal-Guadarrama, L.I.; Ochoa-Rojas, M.ón.d.C.; Méndez, J.é D. 2003: The clinical importance of insulin-like growth factors. Gaceta Medica de Mexico 139(6): 589-599

Mantone, J. 2006: Gain-sharing seems to be working, but......research shows stent savings come from negotiations, not implementations. Modern Healthcare 36(23): 33

Lanier, J.; Loudermilk, K.; Skogsbergh, J.; Clark, R.; Friz, R.; Lopez, F. 2005: Straight talk. new approaches in healthcare. Modern Healthcare 35(45): 31-34

Benko, L.B. 2007: Chains weigh on on access. the FAH joins the throng offering proposals to solve the uninsured crisis, but some say their plan lacks a key element. Modern Healthcare 37(9): 6-7; 16, 1

Anonymous 2005: By the numbers. Largest healthcare financing companies ranked by amount of loans underwritten January through August 2005 (dollar in millions). Modern Healthcare 35(40): 42

Tsilipakos, O.; Koschny, T.; Soukoulis, C.M. 2018: Antimatched Electromagnetic Metasurfaces for Broadband Arbitrary Phase Manipulation in Reflection. Acs Photonics 5(3): 1101-1107

Moon, S. 2005: By the numbers. Largest healthcare mergers announced in 2004 ranked by deal size. Modern Healthcare 35(10): 44

Anonymous 2007: By the numbers. Largest healthcare services mergers and acquisitions announced in 2006. U.S. deals ranked by deal's price. Modern Healthcare 37(4): 34

Moon, S. 2004: By the numbers. Largest healthcare staffing firms ranked by 2003 healthcare staffing revenue. Modern Healthcare 34(29): 32

Galloro, V. 2003: Looking into the future. Predictions don't always come true, but hospitals still must look ahead as aging boomers, booming technology require new solutions. Modern Healthcare 33(16): 28-29; 34

Moon, S. 2004: By the numbers. Largest managed-care organizations. Ranked by commercial HMO enrollment in 2003. Modern Healthcare 34(11): 30

Anonymous 2006: By the numbers. Largest national healthcare associations. Organizations ranked by 2004 revenue, with noted exceptions. Based on Modern Healthcare's review of IRS form 990 filings. Modern Healthcare 36(14): 30

Romano, M.; Benko, L.B. 2006: Med-mal rates are flat: study. Modern Healthcare 36(10): 31

Stires, D. 2004: By the numbers. Mounting medical bills. Fortune 150(3): 34

Moon, S. 2004: By the numbers. Nurse-staffing levels. Modern Healthcare 34(16): 30

Anonymous 2004: By the numbers. Outsourcing. Modern Healthcare Suppl: 50 52

Stires, D. 2004: By the numbers. the bird flu that's sweeping across Asia. Fortune 149(4): 34

Anonymous 2004: By the numbers. The explosion in long-term care insurance. Ahip Coverage 45(3): 14-15

Frayha, H.H.; Al Mazrou, Y.Y. 2005: Vaccination against invasive pneumococcal disease in Saudi Arabia: where do we stand?. Annals of Saudi Medicine 25(2): 90-93

Moon, S. 2004: By the numbers. Top 10 healthcare provider consultants: ranked by 2002 provider revenue. Modern Healthcare 34(42): 50

Moon, S. 2003: By the numbers. Top 15 executive recruitment firms. Modern Healthcare 33(37): 32

Moon, S. 2003: By the numbers. Top 20 healthcare software application providers. Modern Healthcare 33(42): 34

Van Mil, F. 2003: Pharmacy, world and science?. Pharmacy World and Science: Pws 25(4): 127

Moon, S. 2005: By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004. Modern Healthcare 35(1): 32

Uccella, S.; Tibiletti, M.G.; Bernasconi, B.; Finzi, G.; Oldrini, R.; Capella, C. 2005: Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas. Analytical and Quantitative Cytology and Histology 27(5): 241-252

Moon, S. 2004: By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004. Modern Healthcare 34(33): 40

Anonymous 2006: By the numbers. Top business graduate schools for physician-executives. Data collected in March 2006 for the 2005-06 school year. Modern Healthcare 36(18): 30

Moon, S. 2003: By the numbers. Top healthcare bond counsel firms. Modern Healthcare 33(46): 32

Smalley, S. 2003: A new baby debate. Newsweek 141(12): 53

Moon, S. 2004: By the numbers. Top healthcare investment banks ranked by tax-exempt debt issued in 2004 as of Oct. 26. Modern Healthcare 34(46): 31

Moon, S. 2004: By the numbers. Top healthcare software application providers. Ranked by 2003 healthcare revenue. Modern Healthcare 34(20): 34

Moon, S. 2005: By the numbers. Top nursing facility chains ranked by number of beds as of Dec. 31, 2003. Modern Healthcare 35(14): 32

Moon, S. 2004: By the numbers. Top retained executive search consulting firms. Modern Healthcare 34(38): 32

Sanders, P.; Hsu, L.F.; Hocini, M.; Jaïs, P.; Takahashi, Y.; Rotter, M.; Sacher, F.; Pasquié, J.L.; Arentz, T.; Scavée, C.; Garrigue, S.; Clémenty, J.; Haïssaguerre, M. 2004: Mapping and ablation of ventricular fibrillation. Minerva Cardioangiologica 52(3): 171-181

Clayton, C.P.; Grover, A.; O'Connell, M. 2004: By the numbers: data on medical school-based departments of internal medicine. American Journal of Medicine 116(3): 213-216

Rubin, M. 2004: By the numbers: prehospital cardiac arrest research. Jems: a Journal of Emergency Medical Services 29(9): 68-77

Tulloch, P.W.; Citarella, B.B. 2004: By the numbers: using "blended reports" for data-based decision making. Caring: National Association for Home Care Magazine 23(8): 30-33

Dankner, R.; Ben-Dov, I. 2005: By the sweat of your brow shall you eat bread: a blessing or a curse?. Harefuah 144(1): 45-50; 70, 69

Reilly, D.T. 2003: By the way, Doctor. I'm a 52-year-old tennis player who needs a hip replacement. The orthopedists in my area do a metal-ball-in-polyethylene-cup replacement that I'm told lasts 10-15 years. But I've heard that metal-ball-in-metal-cup replacements last longer. What do you think?. Harvard Health Letter 29(1): 8

Robb-Nicholson, C. 2006: By the way, doctor. A family friend just started smoking again. He doesn't smoke while my young daughter and I are there, but his house is saturated with the smell. Is this secondhand smoke? Should I be concerned?. Harvard women's health watch 14(2): 8

Komaroff, A.L. 2006: By the way, doctor. A friend recently recommended that I take the herb ginkgo biloba to protect against getting dementia. Is it effective, and is it safe?. Harvard health letter 32(2): 8

Robb-Nicholson, C. 2003: By the way, doctor. A new television ad says I should ask my doctor about Plavix, a drug that reduces the risk of heart attack and stroke. I'm 65 years old and healthy. Should I be taking Plavix preventively?. Harvard women's health watch 11(3): 8

Robb-Nicholson, C. 2005: Gynecologist or internist?. Harvard Women's Health Watch 12(5): 3

Komaroff, A.L. 2006: By the way, doctor. A recent test showed I have some hip osteopenia. Now every day I take two Tums Ultra (800 mg of calcium) plus a multivitamin (200 mg of calcium). I also get a total of 800 International Units (IU) of vitamin D daily. I've been advised that Tums aren't sufficient. Do I need to switch to a more expensive calcium supplement?. Harvard health letter 31(6): 8

Lee, T.H. 2003: By the way, doctor. After a recent blood pressure check, my doctor bumped up my dose of Lotensin [an ACE inhibitor] from 10 milligrams to 20. I had been taking the 10-mg pill in the morning, but my doctor advised me to take the new, higher dose in the evening. He said most strokes and heart attacks happen in the morning, and that I could get better protection by taking the drug right before. But I read in the Health Letter a couple of months ago. Harvard health letter 28(12): 8

Robb-Nicholson, C. 2003: By the way, doctor. After stopping Prempro last year, I developed really uncomfortable vaginal dryness. My doctor has recommended the vaginal estrogen ring. Is it safe?. Harvard women's health watch 10(6): 8

Lee, T.H. 2003: By the way, doctor. At a hospital near my home, they're using something called endoluminal grafts to fix abdominal aortic aneurysms. They're claiming that you're out of the hospital in one or two days and back on the golf course in a month. Too good to be true?. Harvard health letter 28(7): 8

Robb-Nicholson, C. 2005: By the way, doctor. Can you tell me anything about a new cosmetic treatment called Thermage?. Harvard women's health watch 12(12): 8

Anonymous 2004: By the way, doctor. Do birth control pills increase my risk for getting breast and ovarian cancer? If so, how long can I take the pill and still avoid these risks?. Harvard Women's Health Watch 11(10): 8

Komaroff, A.L. 2005: By the way, doctor. Do you think flu shots might also prevent lung cancer?. Harvard health letter 30(12): 8

Robb-Nicholson, C. 2006: By the way, doctor. Does post-herpetic neuralgia raise C-reactive protein?. Harvard women's health watch 14(3): 8

Komaroff, A.L. 2005: By the way, doctor. Ever since the 1960s, I haven't eaten more than one egg a week because egg yolks have a lot of cholesterol. Now my wife says she heard on the news that it's okay to eat eggs every day. What do you think?. Harvard health letter 30(6): 8

Robb-Nicholson, C. 2003: By the way, doctor. For several years, I've taken the calcium-channel blocker Procardia to control my hypertension. Could it decrease the calcium in my body and thus increase my risk for osteoporosis?. Harvard women's health watch 11(1): 8

Robb-Nicholson, C. 2005: By the way, doctor. For two years in a row, the lab that handles my Pap smears has reported "insufficient cell count". My doctor says it's nothing to worry about, but my health insurance company considers these "abnormal" Paps and has put me in a higher-risk category because of it. Should I be concerned?. Harvard women's health watch 13(3): 8

Komaroff, A.L. 2007: By the way, doctor. How do B vitamins lower your homocysteine level, and how important is it to have a normal level?. Harvard health letter 32(4): 8

Komaroff, A.L. 2006: By the way, doctor. How much alcohol is in a drink? I drink at least two jiggers (three ounces) of gin most days, and lately, I've been drinking three. Is that too much? I understand that women are more easily affected by alcohol than men. Harvard health letter 31(11): 8

Komaroff, A.L. 2006: By the way, doctor. I am 81 with no history of heart problems. I recently developed atrial fibrillation and now take half of a 25-mg tablet of atenolol. The doctor says it's working, but it makes me extremely tired. Could you suggest another medication that I might have better luck with?. Harvard health letter 31(10): 8

Komaroff, A.L. 2004: By the way, doctor. I am a 67-year-old woman. I walk three miles five or six times a week and swim for half an hour every day. I take a diuretic for high blood pressure, a calcium supplement, and vitamins C and E. My HDL level is usually over 100, but it was up to 147 in my most recent cholesterol test (my total cholesterol was 223 and my LDL was 68). Should I be celebrating or worried about an unusually high HDL?. Harvard health letter 29(11): 8

Komaroff, A.L. 2005: By the way, doctor. I am a 73-year-old male. I've been diabetic for 50 years, and had a quintuple bypass eight years ago. I try to get an hour of exercise on a treadmill each day. While working out a couple of days ago, I developed a sudden sharp pain on my left side at about chest level, toward my back. Naturally I stopped, but I wondered when a person like me should call 911. Harvard health letter 31(2): 8

O'Leary, M.P. 2006: By the way, doctor. I developed acute urinary retention after having a pacemaker put in. I'm a 90-year-old man and in pretty good shape considering my age, but I'd rather not have any more procedures. What are my options?. Harvard health letter 31(3): 8

Robb-Nicholson, C. 2003: By the way, doctor. I don't hear nearly as much about hair loss in women as in men. But I'm 65 and have watched my hair thin considerably over the past five or six years. Is there anything I can do about it? What about Rogaine?. Harvard women's health watch 10(11): 8

Anonymous 2004: By the way, doctor. I eat salmon once or twice a week, but the publicity about toxins in farm-raised salmon worries me. Is farm-raised salmon safe?. Harvard Women's Health Watch 11(8): 8

Anonymous 2004: By the way, doctor. I feel tired, and my joints ache. I've been told I have a vitamin B12 deficiency. What is this--and what causes it?. Harvard Women's Health Watch 11(11): 8

Robb-Nicholson, C. 2005: By the way, doctor. I get cold sores every few months. I'm worried I'll have them when I'm away on vacation next month. What can I do to prevent them?. Harvard women's health watch 12(5): 8

Komaroff, A.L. 2004: By the way, doctor. I get mail extolling the virtues of chelation therapy. The claim is that it removes calcium and other metals from the walls of arteries. The key element appears to be EDTA. Since vinegar is also primarily acetic acid, I'm curious whether it could have the same effect. Harvard health letter 29(5): 8

Robb-Nicholson, C. 2004: By the way, doctor. I had pain some bleeding with bowel movements. I thought it was a hemorrhoid, but my doctor says it's an anal fissure. How did I get this, and what's the best way to treat it?. Harvard women's health watch 12(1): 8

Robb-Nicholson, C. 2004: By the way, doctor. I have a cyst on a Bartholin's gland. What causes it, and how can it be prevented?. Harvard women's health watch 11(12): 8

Robb-Nicholson, C. 2005: By the way, doctor. I have a pain in my right buttock, which my doctor says is ischial bursitis. Is there anything I can do for the pain or to make the condition go away?. Harvard women's health watch 13(2): 8

Komaroff, A.L. 2004: By the way, doctor. I have been taking two Advil tablets two or three times per day to reduce pain and inflammation in my knees. Could it be harmful to do this for an extended period of time, say a year?. Harvard health letter 29(12): 8

Robb-Nicholson, C. 2005: By the way, doctor. I have gout. I've read that foods high in purine can aggravate the condition. What is purine, and how can I reduce it in my diet. Harvard women's health watch 12(10): 8

Robb-Nicholson, C. 2005: By the way, doctor. I have irritable bowel syndrome, with frequent bloating and constipation. My doctor prescribed a six-week course of Zelnorm, which really helped. Is it safe to take long-term?. Harvard women's health watch 12(9): 8

Anonymous 2003: By the way, doctor. I have pain on the bottom of my foot that my doctor tells me is plantar fasciitis. It's really interfering with my daily walking routine. What can I do?. Harvard Women's Health Watch 10(12): 8

Lee, T.H. 2003: By the way, doctor. I have several medications that are well beyond their expiration dates. Does that mean that they won't work--or are dangerous?. Harvard health letter 28(9): 8

Arndt, K. 2004: By the way, doctor. I have sun spots on my hands. When and why are freezing treatments a good idea?. Harvard health letter 29(4): 8

Lee, T.H. 2003: By the way, doctor. I just got my cholesterol checked, and I'm confused. LDL is bad and HDL is good, so how can they be combined into an overall number that makes any sense? Isn't that like an accountant mixing debits with credits? Wouldn't it make more sense to have a net cholesterol number (HDL minus LDL), or perhaps a ratio?. Harvard health letter 28(11): 8

Robb-Nicholson, C. 2003: By the way, doctor. I keep hearing that alcohol, even in moderate amounts, raises the risk of developing breast cancer. How does it do that?. Harvard women's health watch 10(9): 8

Olbricht, S. 2003: By the way, doctor. I know I should use sunscreen when I go outdoors in order to reduce my risk for skin cancer. But I've heard that sunscreen blocks my skin's ability to make vitamin D. Is this true? I don't want to miss out on the vitamin D that I need for bone strength. Harvard women's health watch 10(10): 8

LeWine, H. 2005: By the way, doctor. I know someone who lost her sense of taste after years of heavy prescriptions for high blood pressure. Is this a side effect you have to accept, or should my friend's doctor try prescribing a different medication? Is the loss of taste reversible?. Harvard health letter 30(8): 8

Robb-Nicholson, C. 2005: By the way, doctor. I notice that parabens are found in many cosmetics and skin care products. I heard that they're carcinogenic. Is that true?. Harvard women's health watch 12(7): 8

Lee, T.H. 2004: By the way, doctor. I read in the newspaper that angioplasty and stents don't do any good because narrowed arteries aren't the cause of most heart attacks. Is that true?. Harvard health letter 29(9): 8

Lee, T.H. 2003: By the way, doctor. I read in your July 2003 article on the new blood pressure guidelines with interest because I have high blood pressure. But one thing bothers me about articles on blood pressure: they always seem to talk about blood pressure as if it were the same number all day long. In my case, the systolic pressure can vary by 30 points and the diastolic by 15. So which should you use as your blood pressure reading: the average, the highest, or the lowest?. Harvard health letter 29(1): 8

Robb-Nicholson, C. 2004: By the way, doctor. I read recently about a link between antibiotics and breast cancer. What do you make of it?. Harvard women's health watch 11(9): 8

Komaroff, A.L. 2005: By the way, doctor. I read your item about eggs in the April 2005 issue with great interest. My husband has type 2 diabetes and has started eating two eggs about three times a week. He's looking to fill up on low-carb foods he likes. You mentioned that eggs may not be a good idea for people with diabetes. Should he cut back?. Harvard health letter 30(9): 8

Lee, T.H. 2003: By the way, doctor. I recently had an ultrasound to look for gallstones. No gallstones. But they found an abdominal aortic aneurysm instead. The doctors said it's pretty small--only 3.8 centimeters. But I'm worried that it might get larger and break open. Is there anything I can do to prevent it from getting bigger?. Harvard health letter 28(4): 8

Robb-Nicholson, C. 2003: By the way, doctor. I recently read that the new osteoporosis drug Forteo is better than any available alternative. Since so many of us who are postmenopausal are at risk for osteoporosis, shouldn't we be taking it?. Harvard women's health watch 10(7): 8

Komaroff, A.L. 2005: By the way, doctor. I recently started taking Lipitor for high cholesterol. The label says: "Do not eat grapefruit or drink grapefruit juice at any time while taking this medication." My doctor didn't warn me about grapefruit. Several medically trained friends have never heard of such a thing. I love grapefruit. Is there really anything to worry about?. Harvard health letter 30(4): 8

Robb-Nicholson, C. 2007: By the way, doctor. I recently switched from Prilosec to its generic form, omeprazole. The generic form doesn't give me as much relief from heartburn as Prilosec does. Aren't generics supposed to be the same as the brand-name drugs?. Harvard women's health watch 14(5): 8

Robb-Nicholson, C. 2005: By the way, doctor. I seem to sweat a great deal from my hands and underarms, more than my friends do. Sometimes I can't write or shake hands because my palms are dripping with sweat. Is there anything I can do about this embarrassing problem?. Harvard women's health watch 13(1): 8

Komaroff, A.L. 2005: By the way, doctor. I take 20 mg of Lipitor and 10 mg of Zetia. My total cholesterol has declined from 177 to 145, my LDL from 133 to 93, but my "good" HDL cholesterol also went down from 46 to 41. Would you consider my low HDL level a large risk factor? If so, is there a regimen that would increase it?. Harvard health letter 30(3): 8

Komaroff, A.L. 2005: By the way, doctor. I take Pravachol to control my cholesterol, and because of high triglycerides, my doctor wants to add TriCor. But my pharmacist warns against taking both medications. If I don't take TriCor, are there alternatives?. Harvard health letter 30(5): 8

Robb-Nicholson, C. 2005: By the way, doctor. I travel frequently and always carry my estrogen and thyroid pills with me. Could the radiation from airport security alter them or make them less effective?. Harvard women's health watch 12(11): 8

Robb-Nicholson, C. 2007: By the way, doctor. I understand that NSAID patches are used in Europe to treat some kinds of arthritis. Are they available in the United States?. Harvard women's health watch 14(6): 8

Robb-Nicholson, C. 2005: By the way, doctor. I wake up at night with pins and needles in one or both of my hands. I've tried chiropractic, physical therapy, and a special pillow, with no success. What's causing this, and what can I do to stop it?. Harvard women's health watch 12(8): 8

Robb-Nicholson, C. 2004: By the way, doctor. I was astounded to read that women who test positive for the breast cancer gene have as much as an 80% risk of getting breast cancer. Shouldn't we all be tested?. Harvard women's health watch 11(7): 8

Robb-Nicholson, C. 2006: By the way, doctor. I was vaccinated against Lyme disease in 2000. Do I still need to be careful about tick bites?. Harvard women's health watch 13(12): 8

Lee, T.H. 2003: By the way, doctor. I'm 5-foot-8 and 170 pounds, so my BMI is 26. I exercise a lot, and no one thinks I'm overweight. But the BMI charts say I am. What do you think?. Harvard health letter 28(5): 8

Robb-Nicholson, C. 2006: By the way, doctor. I'm 60 and have osteoporosis. My doctor is recommending Fosamax, but I'm concerned about jawbone problems. Are there any other drugs I can take?. Harvard women's health watch 14(4): 8

Hayami, T.; Teramura, K.; Tanaka, T.; Fujimoto, N. 2018: Anti-MDA5 antibody-positive bullous dermatomyositis with thyroid carcinoma. European Journal of Dermatology: Ejd 28(3): 418-419

Lee, T.H. 2003: By the way, doctor. I'm 72, with no history of heart trouble. But my cholesterol is in the 220s, and I have been taking Lipitor for three years. I am thinking about buying a home defibrillator, primarily for myself but also for any emergency (although my wife is 52 and in excellent health). What's your advice?. Harvard health letter 29(2): 8

Komaroff, A.L. 2005: By the way, doctor. I'm 73, in generally good health, but bothered by frequent colds and respiratory infections. I suspect I have a weakened immune system. Are there tests that will tell me if that is so?. Harvard health letter 30(7): 8

Lee, T.H. 2004: By the way, doctor. I'm 74 and in good health with no apparent heart problems. Because I am allergic to aspirin, it has been suggested that I take Plavix. Your thoughts?. Harvard health letter 29(7): 8

O'Leary, M.P. 2003: By the way, doctor. I'm 77 and have an enlarged prostate. I take Proscar once a day and saw palmetto three times a day. Yet I still have to get up two to seven times a night to urinate. What can I do to reduce the frequency of urination?. Harvard health letter 28(6): 8

Komaroff, A.L. 2004: By the way, doctor. I'm 77 and in good health. I believe I'm particularly welcome at the blood bank because I have O-negative blood. I give blood several times a year. At my age, how frequently is it wise to give?. Harvard health letter 29(10): 8

Rich, J.P. 2004: By the way, doctor. I'm 81 and have an enlarged prostate. My urologist checks my prostate three or four times a year with a digital rectal exam and a PSA test. Recently I had blood in my urine. Do you think the digital exam could have caused the bleeding? How often does someone like me need to get a digital rectal exam and a PSA test?. Harvard health letter 29(6): 8

Fujita, Y.; Fukui, S.; Suzuki, T.; Ishida, M.; Endo, Y.; Tsuji, S.; Takatani, A.; Igawa, T.; Shimizu, T.; Umeda, M.; Sumiyoshi, R.; Nishino, A.; Koga, T.; Kawashiri, S.-Y.; Iwamoto, N.; Ichinose, K.; Tamai, M.; Nakamura, H.; Origuchi, T.; Abe, K.; Kawakami, A. 2018: Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome that Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis. Internal Medicine 57(23): 3473-3478

Robb-Nicholson, C. 2003: By the way, doctor. I'm five years into menopause. Recently my breasts became tender and I noticed vaginal secretions, but no bleeding--as if I were about to have a period. Should I be concerned?. Harvard women's health watch 11(4): 8

Komaroff, A.L. 2007: By the way, doctor. I'm having pains on the side of my face, and my doctor says that it's postherpetic neuralgia. But I am puzzled because I had a rash on the inside of my arm, but not on my face. Should I be?. Harvard health letter 32(3): 8

Robb-Nicholson, C. 2006: By the way, doctor. I'm hearing more and more about deterioration of the jawbone associated with bisphosphonate drugs. I've been taking Fosamax for over six years for osteoporosis. What should I do?. Harvard women's health watch 14(1): 8

Anonymous 1997: By the way, doctor. I've always used tap water for drinking and cooking, but I wonder if it's safe. Would I be better off buying a water purifier?. Harvard health letter 23(1): 7

Robb-Nicholson, C. 2004: By the way, doctor. I've been diagnosed with deQuervain's tenosynovitis. What can I do to help it heal?. Harvard women's health watch 12(2): 8

Arndt, K. 2006: By the way, doctor. I've been out in the sun all my life. My forehead has been sunburned a thousand times. I now wear a hat. Is there something I could use to repair the damage to the areas of my forehead that have been sunburned too much?. Harvard health letter 32(1): 8

Robb-Nicholson, C. 2006: By the way, doctor. I've been taking Prilosec for over a year for GERD. Recently, I read that long-term use of proton pump inhibitors increases the risk of certain gastric cancers. Your opinion?. Harvard women's health watch 13(11): 8

Robb-Nicholson, C. 2004: By the way, doctor. I've been told I have lichen sclerosus. What can you tell me about this?. Harvard women's health watch 11(6): 8

Hattori, Y.; Matsuyama, K.; Takahashi, T.; Shu, E.; Kanoh, H.; Seishima, M. 2018: Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom. Case Reports in Dermatology 10(2): 110-114

Robb-Nicholson, C. 2002: By the way, doctor. I've had a pain in my shoulder for two weeks, which my doctor says is tendonitis of my rotator cuff. What can you tell me about this condition? I can't recall doing anything to cause the pain. Harvard women's health watch 9(6): 7-8

Komaroff, A.L. 2004: By the way, doctor. I've heard that statins lower calcium levels in the blood. Should I take a calcium supplement to make up for the deficit and protect my bones, or is low calcium healthy because calcium is a component of the plaque in arteries that causes heart attacks?. Harvard health letter 29(8): 8

Robb-Nicholson, C. 2005: By the way, doctor. I've heard that taking Fosamax for a long time causes the jawbone to deteriorate. Do you know anything about this?. Harvard women's health watch 13(4): 8

Robb-Nicholson, C. 2003: By the way, doctor. I've read that hair analysis can tell me a lot about my health. Is this true?. Harvard women's health watch 11(2): 8

Robb-Nicholson, C. 2004: By the way, doctor. In the winter, my hands get very cold and occasionally turn white. Last year, even my nose got white patches. My doctor calls it a mild case of Raynaud's. What do you think?. Harvard women's health watch 12(3): 8

Robb-Nicholson, C. 2006: By the way, doctor. In your December 2005 article on lung cancer, you mention "certain other airborne substances" as risk factors. What about mold spores?. Harvard women's health watch 13(9): 8

Lee, T.H. 2003: By the way, doctor. Is there any advantage to taking Foxamax with distilled water? The instructions say to take it with "plain water". The city water where I live is loaded with phosphates and other minerals, so I'm worried that my tap water doesn't meet the definition of "plain water". Harvard health letter 28(10): 8

Komaroff, A.L. 2004: By the way, doctor. Much is made about high blood pressure, but little is said when it's really low. At what levels are systolic and diastolic readings considered too low? Are there any symptoms? What about treatments?. Harvard health letter 29(3): 8

De Backer, E.; Gremonprez, Félix.; Brusselle, G.; Depuydt, P.; Van Dorpe, J.; Van Haverbeke, C.; Goeminne, P.C.; Derom, E. 2018: Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report. Acta Clinica Belgica 73(6): 413-417

Lee, T.H. 2006: By the way, doctor. My cholesterol numbers are as follows: Total-220; HDL-82 (it's been anywhere from 75 to 85 for the last 20 years); LDL-150; total-to-HDL ratio-2.7. I'm 85, and the heart doctor wants to put me on a statin. I feel great; I'm not overweight, and I don't have any heart problems. I don't take any medications except a daily 81-mg baby aspirin. Do I need to take a statin?. Harvard health letter 31(8): 8

Robb-Nicholson, C. 2004: By the way, doctor. My doctor told me I'm overdue for a tetanus booster. I'm 60, and I wonder if it's really necessary at my age. Can't I just get one if I get a deep cut?. Harvard women's health watch 11(5): 8

Saad, H.M.; Sim, K.S.; Tan, Y.S. 2018: Antimelanogenesis and Anti-Inflammatory Activity of Selected Culinary-Medicinal Mushrooms. International Journal of Medicinal Mushrooms 20(2): 141-153

Anonymous 2002: By the way, doctor. My gynecologist says that I have atrophic vaginitis and that it's a common problem for menopausal women. In all my reading about menopause, I've never come across this condition. What can you tell me about it?. Harvard women's health watch 9(6): 7

Hodin, R. 2003: By the way, doctor. My mother recently had her gallbladder removed. The doctors say there are "surgical clips" in her. Are they supposed to be there and could they be the reason she is having pains in her side?. Harvard health letter 28(8): 8

Lee, J.-O.; Kim, E.; Kim, J.H.; Hong, Y.H.; Kim, H.G.; Jeong, D.; Kim, J.; Kim, S.H.; Park, C.; Seo, D.B.; Son, Y.-J.; Han, S.Y.; Cho, J.Y. 2018: Antimelanogenesis and skin-protective activities of Panax ginseng calyx ethanol extract. Journal of Ginseng Research 42(3): 389-399

Komaroff, A.L. 2005: By the way, doctor. My systolic blood pressure is 40 points higher in winter than in the summer (160-180 versus 120-140 mm Hg). Do the seasons affect blood pressure. Harvard health letter 30(11): 8

Komaroff, A.L. 2005: By the way, doctor. My wife and I both recently suffered mild strokes. Although we are both recovering, we'd like to consult a physician who specializes in the treatment and prevention of strokes. What medical specialty is devoted to this?. Harvard health letter 30(10): 8

Robb-Nicholson, C. 2006: By the way, doctor. Recently, I read about a new vaccine against cancer of the cervix. Is this something I should consider?. Harvard women's health watch 13(8): 8

Lim, J.W.; Ha, J.H.; Jeong, Y.J.; Park, S.N. 2018: Anti-melanogenesis effect of dehydroglyasperin C through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16F1 melanoma cells. Pharmacological Reports: Pr 70(5): 930-935

Mushlin, S. 2006: By the way, doctor. The air in my apartment gets exceedingly dry during the winter. I started using a nasal decongestant containing oxymetazoline hydrochloride. Now I'm hooked. Even when it's not winter, I can't breathe at night without it. How can I break this addiction?. Harvard health letter 31(12): 8

Robb-Nicholson, C. 2003: By the way, doctor. What can I do about irregular bleeding during perimenopause?. Harvard women's health watch 10(8): 8

Robb-Nicholson, C. 2006: By the way, doctor. What can I do about osteoarthritis of the knee? For several months, I've been taking a glucosamine/chondroitin supplement, but I still get painful flare-ups. Do these supplements really work? What else can I do to ease the pain?. Harvard women's health watch 13(10): 8

Kim, P.S.; Shin, J.H.; Jo, D.S.; Shin, D.W.; Choi, D.-H.; Kim, W.J.; Park, K.; Kim, J.K.; Joo, C.G.; Lee, J.S.; Choi, Y.; Shin, Y.W.; Shin, J.J.; Jeon, H.B.; Seo, J.-H.; Cho, D.-H. 2018: Anti-melanogenic activity of schaftoside in Rhizoma Arisaematis by increasing autophagy in B16F1 cells. Biochemical and Biophysical Research Communications 503(1): 309-315

Keating, N. 2006: By the way, doctor. What does it mean if my fasting blood sugar level is high (135-145) but my glycosylated hemoglobin test is negative?. Harvard health letter 31(9): 8

Zhao, P.; Alam, M.Badrul.; An, H.; Choi, H-Jeong.; Cha, Y.Ho.; Yoo, C-Yeol.; Kim, H-Hyun.; Lee, S-Han. 2018: Antimelanogenic Effect of an Oroxylum indicum Seed Extract by Suppression of MITF Expression through Activation of MAPK Signaling Protein. International journal of molecular sciences 19(3)

Anonymous 1997: By the way, doctor. "I've heard that over-the-counter laxatives cause cancer. Is this true"?. Harvard health letter 23(2): 5

Fuessl, H.S. 2006: By the year 2030 some 40% of the German population could be Type 2 diabetics--the big bang in the public health system. MMW Fortschritte der Medizin 148(21): 27

DiGregorio, B.E. 2007: Deep UV Raman imaging for astrobiology. Analytical Chemistry 79(3): 798

Johnson, H.R.; Vance, R.E. 1954: By us; not for us. American Journal of Nursing 54(7): 835-838

Samuels, S.C. 2004: By way of an introduction. Paving the way for a psychiatric referral. Geriatrics 59(1): 42-43

Perera, G.A. 1963: By way of curiosity. Journal of Medical Education 38: 44-45

West, R.O. 1953: By way of promoting good will they keep patients out of the hospital. Modern Hospital 81(2): 86-87

Gemaehling, P. 1951: By what legal means can we fight against prostitution?. La Prophylaxie Antivenerienne 23(9): 389-400

Folbre, N.; Yoon, J.; Finnoff, K.; Fuligni, A.S. 2005: By what measure? Family time devoted to children in the United States. Demography 42(2): 373-390

Veiros, L.ís.F.; Dazinger, G.; Kirchner, K.; Calhorda, M.J.é; Schmid, R. 2004: By what mechanisms are metal cyclobutadiene complexes formed from alkynes?. Chemistry 10(22): 5860-5870

Balon, R. 2005: By whom and how is the quality of research data collection assured and checked?. PsychoTherapy and Psychosomatics 74(6): 331-335

Vange, B. 2004: By whom are adults with hyperkinetic disorders/ADHD/"DAMP" to be treated?. Ugeskrift for laeger 166(32): 2688-9; author reply 2689-90

Leach, C.W.; Smith, H.J. 2006: By whose standard? the affective implications of ethnic minorities' comparisons to ethnic minority and majority referents. European Journal of Social Psychology 36(5): 747-760

Kaplan, A.R. 1963: By-Laws of American Eugenics Society, Inc. Eugenics quarterly 10: 202-205

Sholomiantsev-Terskii, O.S. 1963: By-Pass Approach to the Anterior Tibial Artery. Khirurgiia 39: 103-106

Anderson, J.C.; Hynes, W. 1965: By-Pass Operation for Strictures of the Deep Urethra. British Journal of Urology 37: 148-156

Game, J.A. 1963: By-Passing Vertebral Artery Occlusion by Extracranial Anastomotic Channels. Proceedings of the Australian Association of Neurologists 72: 5-8

Stillians, A.W. 1950: By-effects of irradiation on the skin. Journal of the American Medical Association 144(9): 743-746

Casal, J. 1958: Urinary complications of rectosigmoid cancer. El Dia Medico 30(37): 1308-Passim

Suomalaisen 1951: By-laws of the Duodecim Society relative to officers. Duodecim; Laaketieteellinen Aikakauskirja 67(2): 193-198

Boikov, I.I. 1959: By-pass anastomoses in inoperable cancer of the esophagus and cardia. Khirurgiia 35: 23-28

Porembskii, O.B. 1957: By-pass circulation in surgery of the large vessels; experimental study. Vestnik Khirurgii Imeni I. I. Grekova 79(11): 121-127

Heberer, G. 1960: By-pass operations in the area of the aorta, and iliac and femoral arteries in chronic occlusive diseases. Langenbecks Archiv für Klinische Chirurgie . Vereinigt Mit Deutsche Zeitschrift für Chirurgie 295: 637-644

Kasai, M.; Ishikawa, T.; Abos; Takahashiy; Terasawa, Y.; Asakawa, H. 1962: By-pass procedure for superior vena cava obstruction. Autogenous vein grafting between the left innominate vein and right auricle. Kyobu Geka. Japanese Journal of Thoracic Surgery 15: 441-445

Creech, O.; Crawford, E.S.; Cooley, D.A.; De Bakey, M.E. 1956: By-pass procedure in treatment of arteriosclerotic occlusion of iliac and femoral arteries. Geriatrics 11(7): 284-288

Shambaugh, G.E. 1962: By-pass surgical techniques in stapes surgery. Archives of Otolaryngology 76: 542-543

Sicard, A.; Natali, J. 1958: By-pass technic in the treatment of vascular obliterative diseases of the extremities. Memoires. Academie de Chirurgie 84(30-31): 962-963

Natali, J. 1962: By-pass using the deep femoral artery. (Technic and indications). Journal de Chirurgie 83: 565-580

Natali, J. 1959: By-pass with preserved homografts in arterial obliterations of the extremities. Revue de l'Atherosclerose 1: 49-59

Pickhardt, P.J. 2003: By-patient performance characteristics of CT colonography: importance of polyp size threshold data. Radiology 229(1): 291-3; author reply 293; discussion 293

Wong, W.; Eiser, A.R.; Mrtek, R.G.; Heckerling, P.S. 2004: By-person factor analysis in clinical ethical decision making: Q methodology in end-of-life care decisions. American Journal of Bioethics: Ajob 4(3): W8-22

Jarosch, K. 1961: By-products in alcoholic beverages. Zeitschrift für Arztliche Fortbildung 55: 1132-1137

Anonymous 1961: By-products of medical success. Glaxo Volume; An Occasional Contribution to the Science and Art of Medicine 22: 5-10

Falandysz, J.; Nose, K.; Mostrag, A.; Ishikawa, Y.; Noma, Y.; Sakai, S. 2005: By-side chlorodibenzo-P-dioxins and chlorodibenzofurans in technical chlorobiphenyl formulations of aroclor 1268, chlorofen, and clophen T 64. Journal of Environmental Science and Health. Part A Toxic/Hazardous Substances and Environmental Engineering 40(9): 1665-1678

Noma, Y.; Yamamoto, T.; Falandysz, J.; Lukaszewicz, E.; Gutfrańska, A.; Sakai, S. 2004: By-side impurities in chloronaphthalene mixtures of the Halowax series: all 12 chlorobenzenes. Journal of Environmental Science and Health. Part A Toxic/Hazardous Substances and Environmental Engineering 39(8): 2011-2022

Noma, Y.; Yamamoto, T.; Falandysz, J.; Gutfrańska, A.; Lukaszewicz, E.; Sakai, S. 2004: By-side impurities in chloronaphthalene mixtures of the Halowax series: all 19 chlorophenols. Journal of Environmental Science and Health. Part A Toxic/Hazardous Substances and Environmental Engineering 39(8): 2023-2034

Noma, Y.; Minetomatsu, K.; Falandysz, J.; Swietojańska, A.; Flisak, M.; Miyaji, K.; Sakai, S. 2005: By-side impurities in chloronaphthalene mixtures of the Halowax series: all 75 chlorodibenzo-p-dioxins. Journal of Environmental Science and Health. Part A Toxic/Hazardous Substances and Environmental Engineering 40(1): 77-89

Raymond, P. 2003: Bye-bye benzocaine?. Nursing 33(7): 10

Rico Irlés, J. 2004: Bye-bye to internal medicine?. Anales de Medicina Interna 21(11): 521-522

Blair, R. 2005: Bye-bye, foot pedal--hello, efficiency. Health Management Technology 26(8): 40-41

Hutton, S.F. 2006: Byetta (exenatide): what's your gut feeling?. South Dakota Medicine: the Journal of the South Dakota State Medical Association 59(1): 16-17

Kennedy, J. 1957: Bygones of a Bundu bone thrower. i. Central African Journal of Medicine 3(6): 235-240

Kennedy, J. 1957: Bygones of a Bundu bone thrower. Ii. Central African Journal of Medicine 3(7): 272-274

Rusing, F. 1951: Byk M 1 in the therapy of spastic conditions. Die Medizinische Welt 20(43): 1355-1356

Richter, O. 1953: Problem of ambulatory therapy of pulmonary tuberculosis with isonicotinic hydrazide. Zeitschrift für Arztliche Fortbildung 47(3): 74-80

Linar, E.I. 1955: Bykov-Kurtsin's method of clinical examination of gastric juice in surgical practice. Voprosy Kliniki i Lecheniia Zlokachestvennykh Novoobrazovanii 2: 93-108

Horty, J.F. 1962: Bylaw wording can lead to legal action. Modern Hospital 99: 93-94

Gerard, F.P.; Sabety, A.M.; Demarco, R. 1965: Bylaws of the International Association for the Scientific Study of Mental Deficiency. Journal of Mental Deficiency Research 9: 150-155

Uniat, S.J. 1965: Bylaws of the Virginia Dental Service Plan. Virginia Dental Journal 42: 36-38

Dal, D.; Salman, E.; Başgül, E. 2003: Byler's disease and anesthetic consideration. Turkish Journal of Pediatrics 45(1): 74-77

Tarnow, E. 2004: Byline corruption can only be controlled by true stakeholders. Medgenmed: Medscape General Medicine 6(3): 10

Gordon, W. 1963: Bypass for Malignant Obstruction of the Esophagus. Annals of Surgery 158: 47-50

Buckwalter, J.A.; Lawton, R.L.; Tidrick, R.T. 1965: Bypass Operations for Neoplastic Biliary Tract Obstruction. American Journal of Surgery 109: 100-106

Yamauchi, H.; Tu, W.H. 1964: Bypass Shunt--A Useful Adjunct to Twin-Coil Artificial Kidney. New England Journal of Medicine 271: 618-619

Warren, R. 1956: Bypass arterial graft between splenic and iliofemoral arteries; method of treating aortic or iliac obstruction with unilateral symptoms. A.M.A. Archives of Surgery 72(1): 57-63

Hilker, M.; Buerke, M.; Lehr, H.A.; Oelert, H.; Hake, U. 2002: Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts. Heart Surgery Forum 5(Suppl 4): S331-S341

Fernandez, G.C. 2005: Bypass graft imaging and coronary anomalies in MDCT. European Radiology 15(Suppl 2): B59-B61

Cate, W.R. 1959: Bypass grafts in small arteries: an experimental comparison of freeze-dried arterial homografts, autogenous vein and crimped dacron. American Surgeon 25(7): 523-527

Henke, K.; Eigsti, J. 2003: Bypass injury: implications of cardiopulmonary bypass. Dimensions of Critical Care Nursing: Dccn 22(2): 64-70

Anonymous 2004: Bypass linked to better survival rates in high-risk patients. Heart Advisor 7(7): 2

Preise, D.; Mazor, O.; Koudinova, N.; Liscovitch, M.; Scherz, A.; Salomon, Y. 2003: Bypass of tumor drug resistance by antivascular therapy. Neoplasia 5(6): 475-480

Hardin, C.A. 1962: Bypass saphenous grafts for the relief of venous obstruction of the extremity. Surgery Gynecology and Obstetrics 115: 709-712

Lemenev, V.L.; Mikhaĭlov, I.P.; Zhulin, D.V.; Iofik, V.V.; Lavrenov, V.N.; Shcherbiuk, A.A. 2003: Bypass surgeries from remote vascular beds in the treatment of critical limb ischemia in elderly and old patients. Khirurgiia 12: 27-33

Legemate, D.A. 2006: Bypass surgery and balloon angioplasty did not differ for amputation-free survival in severe limb ischemia. Acp Journal Club 144(3): 69

Kang, M.; Park, S-Hyoung.; Oh, S.Woong.; Lee, S.Eun.; Yoo, J.Ah.; Nho, Y.Hwa.; Lee, S.; Han, B.Seok.; Cho, J.Youl.; Lee, J. 2018: Anti-melanogenic effects of resorcinol are mediated by suppression of cAMP signaling and activation of p38 MAPK signaling. Bioscience Biotechnology and Biochemistry 82(7): 1188-1196

Ornato, J.P. 2003: Bypass surgery in the elderly is feasible. Heart bypass surgery can benefit people in their mid-70s and beyond, though recovery may take longer than in younger people. Health News 9(12): 8-9

Gilfillan, I.S. 2004: Bypass surgery mortality is blunt measure of performance. Bmj 329(7470): 856

Schniewind, B.; Bestmann, B.; Kurdow, R.; Tepel, J.; Henne-Bruns, D.; Faendrich, F.; Kremer, B.; Kuechler, T. 2006: Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Annals of Surgical Oncology 13(11): 1403-1411

Hirose, H.; Amano, A.; Takahashi, A. 2004: Bypass to the distal right coronary artery using in situ gastroepiploic artery. Journal of Cardiac Surgery 19(6): 499-504

Takagi, H.; Furukawa, M.; Kato, T.; Matsuno, Y.; Umemoto, T. 2006: Bypass versus angioplasty in severe ischaemia of the leg. Lancet 367(9525): 1815; author reply 1815-6

Anonymous 2003: Bypass: what you need to know. Steps patients take before and after surgery can aid recovery. Heart Advisor 6(7): 4-5

Hamdan, A.D.; Rayan, S.S.; Hook, S.C.; Campbell, D.R.; Akbari, C.M.; LoGerfo, F.W.; Pomposelli, F.B. 2002: Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vascular and Endovascular Surgery 36(1): 59-63

Kawahara, M.; Ueda, H.; Morita, S.; Tsumoto, K.; Kumagai, I.; Nagamune, T. 2003: Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch. Nucleic Acids Research 31(7): E32

Luehrs, C. 2007: Bypassing rage. American Journal of Nursing 107(3): 96

Becker, C. 2003: Bypassing the pump. new analysis offers heartening mortality data for proponents of off-pump coronary artery procedure. Modern Healthcare 33(10): 36-40

Angeletti, A. 1953: Byproducts of the penicillin industry. Minerva Medica 44(23): Varia: 418-422

Muss, H.B.; Kannedy, B.James. 2005: Byrl James Kennedy, MD. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(15): 3297-3298

Baensch, W.E.; Kirklin, B.R. 1957: Byrl R. Kirklin, 1888-1957. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 86(5): 675

Hodgson, J.R.; Kirklin, B.R. 1959: Byrl Raymond Kirklin. Gastroenterology 36(5): 714-715

Weber, H.M.; Kirklin, B.R. 1957: Byrl Raymond Kirklin, 1888-1957. American Journal of Roentgenology Radium Therapy and Nuclear Medicine 78(5): 906-910

Hinshaw, H.C.; Hall, B.E. 1964: Byron Ellsworth Hall, M.D., Ph.D. Transactions of the American Clinical and Climatological Association 76: 51-53

Reploh, H.; Klosterkoetter, W. 1964: Byssinosis. Deutsche Medizinische Wochenschrift 89: 2198-2203

Wegmann, T.; Galletti, P.; Amrein, H.P. 1958: Byssinosis (pneumoconiosis due to cotton dust). Schweizerische Medizinische Wochenschrift 88(18): 437-438

Dollery, C.T.; Hill, D.W.; Mailer, C.M.; Ramalho, P.S. 1964: Byssinosis and Atmospheric Pollution. Lancet 2(7354): 299-300

Tuypens, E. 1961: Byssinosis among cotton workers in Belgium. British Journal of Industrial Medicine 18: 117-119

Meiklejohn, A. 1963: Byssinosis in Great Britain. Internationales Archiv für Gewerbepathologie und Gewerbehygiene 20: 49-71

Sassi, C.; Cavagna, G.; Finulli, M. 1962: Byssinosis in a cotton mill in Lombardy. La Medicina del Lavoro 53: 673-682

Bouhuys, A. 1963: Byssinosis in a cotton weaving mill. Archives of Environmental Health 6: 465-468

Schilling, R.S. 1956: Byssinosis in cotton and other textile workers. Lancet 271(6937): 261-265 Contd

Schilling, R.S.F. 1952: Byssinosis in the British cotton industry. Proceedings of the Royal Society of Medicine 45(9): 601-603

Schilling, R.S.F. 1950: Byssinosis in the British cotton textile industry. British Medical Bulletin 7(1-2): 52-56

Muller, L. 1962: Byssinosis in the Netherlands. Internationales Archiv für Gewerbepathologie und Gewerbehygiene 19: 175-183

Pasternak, A.E. 1962: Byssinosis. (Review of the literature from 1958 to 1961). Gigiena i Sanitariia 27: 75-78

Houbraken, J.; Samson, R.A.; Frisvad, J.C. 2006: Byssochlamys: significance of heat resistance and mycotoxin production. Advances in Experimental Medicine and Biology 571: 211-224

Mori, T.; Shin-ya, K.; Aihara, M.; Takatori, K.; Hayakawa, Y. 2003: Byssochlamysol, a new antitumor steroid against IGF-1-dependent cells from Byssochlamys nivea. I. Taxonomy, fermentation, isolation and biological activity. Journal of Antibiotics 56(1): 1-5

Mori, T.; Shin-ya, K.; Takatori, K.; Aihara, M.; Hayakawa, Y. 2003: Byssochlamysol, a new antitumor steroid against IGF-1-dependent cells from Byssochlamys nivea. II. Physico-chemical properties and structure elucidation. Journal of Antibiotics 56(1): 6-8

Anonymous 2005: Bystander CPR: a new video-based training program delivers the right message to the right people. JEMS: a journal of emergency medical services 30(12): 18-19

Bangs, S.C.; McMichael, A.J.; Xu, X.-N. 2006: Bystander T cell activation--implications for HIV infection and other diseases. Trends in Immunology 27(11): 518-524

Chada, S.; Mhashilkar, A.M.; Ramesh, R.; Mumm, J.B.; Sutton, R.B.; Bocangel, D.; Zheng, M.; Grimm, E.A.; Ekmekcioglu, S. 2004: Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism. Molecular Therapy: the Journal of the American Society of Gene Therapy 10(6): 1085-1095

Molin, D. 2004: Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis. Upsala Journal of Medical Sciences 109(3): 179-228

Yan, Y.; Rubinchik, S.; Wood, A.L.; Gillanders, W.E.; Dong, J-Yun.; Watson, D.K.; Cole, D.J. 2006: Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Molecular Therapy: the Journal of the American Society of Gene Therapy 13(2): 357-365

Grandi, C.; Moccaldi, R. 2005: Bystander effect: critical review and implications for risk assessment in radioprotection. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 27(1): 21-34

Dahle, J.; Kvam, E.; Stokke, T. 2005: Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet a and B radiation. Journal of Carcinogenesis 4: 11

Preston, R.Julian. 2005: Bystander effects, genomic instability, adaptive response, and cancer risk assessment for radiation and chemical exposures. Toxicology and Applied Pharmacology 207(2): 550-556

Baren, K.B. 2004: Bystander emotional distress: should third parties recover regardless of the negligent tort?. Journal of Legal Medicine 25(3): 351-367

Pinto, M.; Azzam, E.I.; Howell, R.W. 2006: Bystander responses in three-dimensional cultures containing radiolabelled and unlabelled human cells. Radiation Protection Dosimetry 122(1-4): 252-255

Bäckström, N.F.; Dahlgren, U.I.H. 2004: Bystander suppression of collagen-induced arthritis in mice fed ovalbumin. Arthritis Research and Therapy 6(2): R151-R160

Pelinka, L.E.; Thierbach, A.R.; Reuter, S.; Mauritz, W. 2004: Bystander trauma care--effect of the level of training. Resuscitation 61(3): 289-296

Albert, P.; Handel, J.; Yeghiayan, P.; Sadler, M.A. 2002: Bystander trauma in the World Trade Center disaster. Emergency Radiology 9(1): 32-34

Ito, A.; Shinkai, M.; Bouhon, I.A.; Honda, H.; Kobayashi, T. 2000: Bystander-killing effect and cyclic induction of TNF-alpha gene under heat-inducible promoter gadd 153. Journal of Bioscience and Bioengineering 90(4): 437-441

Berry, S. 2006: Bystanders. Jems: a Journal of Emergency Medical Services 31(11): 152

Demirovic, J.; Li, Y-Peng. 2005: Bystanders of out-of-hospital sudden heart attack: knowledge and behaviors among older African Americans. American Journal of Geriatric Cardiology 14(4): 171-175

Mudde, A.N.; Hoefnagels, C.J.; Van Wijnen, L.G.C.; Kremers, S.P.J. 2007: Bystanding an abused child: testing the applicability of the stages of change construct. Health Education Research 22(1): 128-138

Dunn, C.L. 2005: Byte the technology bullet. Mgma Connexion 5(1): 23-24

Gulotta, S. 1953: Bywater's syndrome and its therapy. Annali di Medicina Navale 58(4): 363-379

Letac, R.; Letac, S.; Chassaigne, J.P. 1963: Bywaters' Syndrome Appearing after a Wound of the Common Femoral Artery without Muscular Injury. Annales de Chirurgie Thoracique et Cardio-Vasculaire 2: 469-472

Congourdeau, M.-H.él.èn. 2004: Byzantine medicine. La Revue du Praticien 54(15): 1733-1737

Huard, P.; Theodorides, J. 1959: Byzantine medicine (330-1453). Concours Medical 81: 4315-9; contd

Arvidsson, S.O.; Edlen, A.; Soderlund, J.; Strandquist, S. 1956: Bz 55 diabetes therapy; preliminary results in a series of 65 cases. Svenska Lakartidningen 53(28): 1788-1794

Kluger, J. 2003: Bzzzz ... slap!. Time 162(1): 84-85

Koorengevel, K.M.; Verhey, F.R.J. 2006: Bálint's syndrome: seeing blind. Tijdschrift Voor Psychiatrie 48(4): 319-323

Juhász, A.; Larroque, O.R.; Tamás, L.; Hsam, S.L.K.; Zeller, F.J.; Békés, F.; Bedo, Z. 2003: Bánkúti 1201--an old Hungarian wheat variety with special storage protein composition. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 107(4): 697-704

Behrman, W. 1950: Bárány's therapy of tinnitus. Nordisk Medicin 44(43): 1720-1721

Levi, D.; Benguria, R. 1980: Bäcklund transformations and nonlinear differential difference equations. Proceedings of the National Academy of Sciences of the United States of America 77(9): 5025-5027

Benguria, R.; Case, K.M. 1980: Bäcklund transformations for multidimensional sine-Gordon equations. Proceedings of the National Academy of Sciences of the United States of America 77(8): 4393-4394

Wentholt, H.M.; Hadders, H.N. 1953: Bäfverstedt's benign cutaneous lymphadenosis. Nederlands Tijdschrift Voor Geneeskunde 97(35): 2256-2261

Ly, F.; Samb, N.D.; Mahé, A. 2003: Béjel. Annales de Dermatologie et de Venereologie 130(11): 1085-1086

Miskolczy-Fodor, F. 1957: Békésy's differential threshold in bone conduction and recruitment. Practica Oto-Rhino-Laryngologica 19(4): 282-288

Haranghy, L.; Entz Bela 1959: Béla Entz, 1877-1959. Orvosi Hetilap 100(5): 165-167

Minker, E.; Issekutz, Béla. 2006: Béla Issekutz was born 120 years ago. Orvosi Hetilap 147(50): 2425-2432

Tapie, J.; Monnier, J.; Garipuy, J.; Delaude, A.; Bouissou, H. 1950: Bériel's orbital punction and injection of streptomycin through the sphenoid fissure in treatment of tuberculous meningitis. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 66(15-16): 698-705

Khoshhal, K.I.; Ibrahim, A.F.; Al-Nakshabandi, N.A.; Zamzam, M.M.; Al-Boukai, A.A.; Zamzami, M.M. 2004: Böhler's and Gissane's angles of the calcaneus in the Saudi population. Saudi Medical Journal 25(12): 1967-1970

Fredholm, B.; Uvnas, B. 2004: Börje Uvnäs and the rise of modern pharmacology. Trends in Pharmacological Sciences 25(4): 170-171

Garozzo, G.; Nuciforo, G.; Rocchi, C.M.; Bonanno, N.M.; Sampugnaro, E.G.; Piccione, S.; Di Stefano, A.; Acquaviva, G.; Barberi, A.L.; Panella, M. 2003: Büschke-Lowenstein tumour in pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology 111(1): 88-90

Kruh, J.; Schapira, G.; Dreyfus, J.C. 1960: C 14] valine in proteins of the subcellular fraction of rabbit reticulocytes. Biochimica et Biophysica Acta 39: 157-159

Bradeanu, I.L.; Flesch, R.; Kosugi, N.; Pavlychev, A.A.; Rühl, E. 2006: C 1s -->pi* excitation in variable size benzene clusters. Physical Chemistry Chemical Physics: Pccp 8(16): 1906-1913

Ross Russell, R.I. 2006: C 3, 4 and 5, keep the diaphragm alive. Intensive Care Medicine 32(8): 1109-1111

App, A.A.; Jagendorf, A.T. 1964: C Amino Acid Incorporation by Spinach Chloroplast Preparations. Plant Physiology 39(5): 772-776

de Villiers, J.C.; Leipoldt, C.F.Louis. 2004: C F L Leipoldt (1880 - 1947)--journalist doctor. South African Medical Journal 94(7): 552-556

Kurtzman, D.J.B.; Vleugels, R.A. 2018: Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. Journal of the American Academy of Dermatology 78(4): 776-785

Millard, C.KILLICK. 1952: C KILLICK Millard. British Medical Journal 1(4762): 820-821

Kannemeyer, J.C.; Leipoldt, C.L.; Kaplan, R.M.; Gray, S.; Forsyth, J.R.L.; O'Connor, M. 2005: C Louis Leipoldt view on sexuality. South African Medical Journal 95(8): 576-581

Olah, G.A.; Berrier, A.L.; Prakash, G.K. 1981: C NMR chemical shift correlations in application of "tool of increasing electron demand" to stable long-lived carbocations: Comprehensive evaluation. Proceedings of the National Academy of Sciences of the United States of America 78(4): 1998-2002

Ramos, A.; Jordan, K.N.; Cogan, T.M.; Santos, H. 1994: C Nuclear Magnetic Resonance Studies of Citrate and Glucose Cometabolism by Lactococcus lactis. Applied and Environmental Microbiology 60(6): 1739-1748

Stidham, M.A.; Moreland, D.E.; Siedow, J.N. 1983: C Nuclear Magnetic Resonance Studies of Crassulacean Acid Metabolism in Intact Leaves of Kalanchoë tubiflora. Plant Physiology 73(2): 517-520

Martin, F.; Canet, D.; Marchal, J.P. 1985: C Nuclear Magnetic Resonance Study of Mannitol Cycle and Trehalose Synthesis during Glucose Utilization by the Ectomycorrhizal Ascomycete Cenococcum graniforme. Plant Physiology 77(2): 499-502

Matthews, C.M. 1965: C Omparison of Isotopes for Scanning. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 6: 155-168

Hanson, A.D.; Rhodes, D. 1983: C Tracer Evidence for Synthesis of Choline and Betaine via Phosphoryl Base Intermediates in Salinized Sugarbeet Leaves. Plant Physiology 71(3): 692-700

Kjeldsen, F.; Silivra, O.A.; Ivonin, I.A.; Haselmann, K.F.; Gorshkov, M.; Zubarev, R.A. 2005: C alpha-C backbone fragmentation dominates in electron detachment dissociation of gas-phase polypeptide polyanions. Chemistry 11(6): 1803-1812

Stievano, L.; Piovan, E.; Amadori, A. 2004: C and CX3C chemokines: cell sources and physiopathological implications. Critical Reviews in Immunology 24(3): 205-228

Olah, G.A.; Garcia-Luna, A. 1980: C and Hg nuclear magnetic resonance spectroscopic study of alkenemercurinium ions: Effect of methyl substituents on Hg chemical shifts. Proceedings of the National Academy of Sciences of the United States of America 77(9): 5036-5039

Cliquet, J.B.; Deléens, E.; Mariotti, A. 1990: C and N Mobilization from Stalk and Leaves during Kernel Filling by C and N Tracing in Zea mays L. Plant Physiology 94(4): 1547-1553

De Lima, M.A.; de Lima, L.M.B.; Freitas, L.L.ís.L.; Barbosa, P.íc.F.T.; Borges, M.d.F.át.; Reis, L.; Pereira, G.d.A. 2003: C cells in the thyroid of pinealectomized rats. Revista do Hospital das Clinicas 58(1): 21-26

Surawicz, C.M. 2006: C difficile--C'est Difficile?. Gastroenterology 131(3): 964-966

Loewenstein, W.R.; Goto, K.; Noback, C. 1962: C fibre innervation of a mechanoreceptor. Experientia 18: 460

Zamyslova, K.N.; Iurazh, V.I. 1960: C inical observations on the effect of reserpine on coronary circulation in patients with hypertension. "laboratorio;" Analisis Clinicos Bacteriologia Inmunologia Parasitologia Hematologia Anatomia Patologica Quimica Clinica 38: 90-95

Copley, L. 2004: C is for communication. Nursing Standard: 1987) 19(8): 19

Robbins, J.E. 1987: C nuclear magnetic resonance studies of propionate catabolism in methanogenic cocultures. Applied and Environmental Microbiology 53(9): 2260-2261

Borchert, R.; Everett, G.W. 1987: C nuclear magnetic resonance study of acetate incorporation into malate during ca-uptake by isolated leaf tissues. Plant Physiology 84(3): 944-949

Olah, G.A.; Prakash, G.K.; Liang, G.; Henold, K.L.; Haigh, G.B. 1977: C nuclear magnetic resonance study of five- and six-coordinated carbon in nonclassical organometallic compounds: Dimeric trialkyl-, tricyclopropyl-, and triarylaluminums and some nido and closo carboranes. Proceedings of the National Academy of Sciences of the United States of America 74(12): 5217-5221

Garbow, J.R.; Ferrantello, L.M.; Stark, R.E. 1989: C nuclear magnetic resonance study of suberized potato cell wall. Plant Physiology 90(3): 783-787

O'leary, M.H.; Jaworski, R.J.; Hartman, F.C. 1979: C nuclear magnetic resonance study of the CO(2) activation of ribulosebisphosphate carboxylase from Rhodospirillum rubrum. Proceedings of the National Academy of Sciences of the United States of America 76(2): 673-675

Biban, P.; Vanzati, M.; Ghizzi, C.; Benedetti, M. 2005: C protein C in sepsis of the newborn and infant. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 27(5): 39-41

Tomai, F. 2004: C reactive protein and microvascular function. Heart 90(7): 727-728

Mehra, A.; Langkamer, V.G.; Day, A.; Harris, S.; Spencer, R.F. 2005: C reactive protein and skin temperature post total knee replacement. Knee 12(4): 297-300

Sisti, M.A.; Pellegrino, V.; Sozio, N. 1958: C reactive protein and the Katz index. I. Comparative studies in pulmonary tuberculosis. Lotta Contro la Tubercolosi 28(11-12): 1191-1196

Sirijaichingkul, S.; Tiamkao, S.; Sawanyawisuth, K.; Chotmongkol, V. 2005: C reactive protein for differentiating bacterial from aseptic meningitis in Thai patients. Journal of the Medical Association of Thailand 88(9): 1251-1256

Rahman, S.; Mozziconacci, P. 1957: C reactive protein in acute articular rheumatism. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 33(34): 2179-2186

Jansson, E.; Jalava, L.; Wager, O. 1959: C reactive protein in bacterial meningitis. Annales Medicinae Experimentalis et Biologiae Fenniae 37: 371-376

Magli, G. 1958: C reactive protein in gynecological pathology. Archivio di Ostetricia E Ginecologia 63(2): 227-232

Lojacono, F. 1958: C reactive protein in infants with intestinal diseases. Gazzetta Medica Italiana 117(5): 191-193

Wager, O.; Jansson, E. 1957: C reactive protein in serous meningitis and paralytic poliomyelitis. Annales Medicinae Experimentalis et Biologiae Fenniae 35(3): 352-356

Ghislandi, E. 1958: C reactive protein in silicosis and silicotuberculosis. La Medicina del Lavoro 49(3): 173-181

Bellomo, G.; Muscolino, F. 1959: C reactive protein in umbilical cord blood and in various physiological conditions in the newborn. Il Lattante 30(5): 264-270

Koskinen, P. 1958: C reactive protein in various pathological conditions. Duodecim; Laaketieteellinen Aikakauskirja 74(1): 49-55

Rossetti, C.; Marson, G.B.; Galla, F. 1958: C reactive protein in various skin diseases. Minerva Dermatologica 33(3): 82-84

Biasucci, L.M.; Giubilato, G.; Biondi-Zoccai, G.; Sanna, T.; Liuzzo, G.; Piro, M.; De Martino, G.; Ierardi, C.; dello Russo, A.; Pelargonio, G.; Bellocci, F.; Crea, F. 2006: C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator. Heart 92(8): 1147-1148

Loublie, G.; Carlotti, J. 1951: C se of ovarian hypogenesis. Journal des Praticiens; Revue Generale de Clinique et de Therapeutique 65(22): 265-267

Lateur, L. 2004: C sign comments. Radiology 231(3): 924

Taniguchi, A.; Tanaka, Y.; Kadono, K.; Takakura, Y.; Kurumatani, N. 2003: C sign for diagnosis of talocalcaneal coalition. Radiology 228(2): 501-505

Heller, W.T.; Vigil, D.; Brown, S.; Blumenthal, D.K.; Taylor, S.S.; Trewhella, J. 2004: C subunits binding to the protein kinase a Ri alpha dimer induce a large conformational change. Journal of Biological Chemistry 279(18): 19084-19090

Jensen, L.Okkels.; Petersen, P.Edvard.; Siboni, A.H. 2005: C vitamin deficiency in alcoholics. Ugeskrift for Laeger 167(39): 3707; Author Reply 3707

Mueller-Eberhard, H.J.; Lepow, I.H. 1965: C'1 Esterase Effect on Activity and Physicochemical Properties of the Fourth Component of Complement. Journal of Experimental Medicine 121: 819-833

Kater, C.E. 2006: C'est si bone. Arquivos Brasileiros de Endocrinologia e Metabologia 50(4): 576-577

Langner, M.; Bolm, C. 2004: C(1)-symmetric sulfoximines as ligands in copper-catalyzed asymmetric Mukaiyama-type aldol reactions. Angewandte Chemie 43(44): 5984-5987

Wang, Y-qing.; Tian, W.; Liu, B.; Li, Q.; Hu, L.; Li, Z-yu.; Yuan, Q. 2004: C(1-2) posterior transarticular screw fixation (Magerl's technique) for patients with incompletely-reduced atlantoaxial dislocation. Zhonghua Yi Xue Za Zhi 84(8): 649-652

Bloom, B.M.; Agnello, E.J.; Laubach, G.D. 1956: C(14)-substituted corticosteroids; some D ring transformations in the compound S series. Experientia 12(1): 27-30

Lardy, H.; Marwah, A.; Marwah, P. 2005: C(19)-5-ene steroids in nature. Vitamins and Hormones 71: 263-299

Jen, T.; Wolff, M.E. 1962: C(19)-Substituted Steroid Hormone Analogs. I. 17beta-Hydroxy-3- Oxoandrost-4-Ene-19-Nitrile. Journal of Medicinal and Pharmaceutical Chemistry 5: 876-878

O'Grady, J. 2004: C(2) monitoring: out of the blocks but with some way to go!. Transplantation 77(11): 1639

Desimoni, G.; Faita, G.; Jørgensen, K.A. 2006: C(2)-symmetric chiral bis(oxazoline) ligands in asymmetric catalysis. Chemical Reviews 106(9): 3561-3651

Beyer, E.M.; Sundin, O. 1978: C(2)H(4) metabolism in morning glory flowers. Plant Physiology 61(6): 896-899

Beyer, E.M. 1975: C(2)H(4): Its Incorporation and Metabolism by Pea Seedlings under Aseptic Conditions. Plant Physiology 56(2): 273-278

Beyer, E.M. 1977: C(2)H(4): Its Incorporation and Oxidation to CO(2) by Cut Carnations. Plant Physiology 60(2): 203-206

Beyer, E.M. 1975: C(2)H(4): its purification for biological studies. Plant Physiology 55(5): 845-848

Cohen, J.D.; Baldi, B.G.; Slovin, J.P. 1986: C(6)-[benzene ring]-indole-3-acetic Acid: a new internal standard for quantitative mass spectral analysis of indole-3-acetic Acid in plants. Plant Physiology 80(1): 14-19

Ryan, J.M.; Xu, Z. 2004: C(6)H(5)NH(CH(3))(2)](2)Te(2)I(10): secondary I...i bonds build up a 3D network. Inorganic Chemistry 43(14): 4106-4108

Coffey, T.; Krim, J. 2006: C(60) molecular bearings and the phenomenon of nanomapping. Physical Review Letters 96(18): 186104

Sánchez, L.; Sierra, M.ía.; Martín, N.; Guldi, D.M.; Wienk, M.W.; Janssen, R.é A.J. 2005: C(60)-exTTF-C(60) Dumbbells: cooperative effects stemming from two C(60)s on the radical ion pair stabilization. Organic Letters 7(9): 1691-1694

Kim, M.G.; Bodor, E.T.; Wang, C.; Harden, T.K.; Kohn, H. 2003: C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists. Journal of Medicinal Chemistry 46(11): 2216-2226

Kim, M.G.; Bodor, E.T.; Harden, T.K.; Kohn, H. 2004: C(8)-substituted 1-azabicyclo[3.3.1]non-3-enes: a novel scaffold for muscarinic receptor ligands. Bioorganic and Medicinal Chemistry 12(9): 2357-2367

Matsunaga, T.; Kogawa, K.; Fujimi, A.; Takizawa, K.; Takahira, N.; Takemoto, N.; Tanaka, I.; Akiyama, T.; Sato, T.; Takayama, T.; Terui, T.; Sakamaki, S.; Niitsu, Y. 2003: C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective. International Journal of Clinical Oncology 8(5): 326-331

Brunet, J.L. 1965: C(New Concept of Outfitting an Operating Room). Canadian Anaesthetists' Society Journal 12: 161-172

Licini, G.; Bonchio, M.; Broxterman, Q.B.; Kaptein, B.; Moretto, A.; Toniolo, C.; Scrimin, P. 2006: C(alpha)-tetrasubstituted amino acid based peptides in asymmetric catalysis. Biopolymers 84(1): 97-104

Budzianowski, J.; Pakulski, G. 1988: C, O- and C-Glycosylflavones from Stellaria media. Planta Medica 54(6): 576

Snyder, C.A.; Selegue, J.P.; Dosunmu, E.; Tice, N.C.; Parkin, S. 2003: C,O-dialkylation of Meldrum's acid: synthesis and reactivity of 1,3,7,7-tetramethyl-4H,10H-6,8,9-trioxa-2-thiabenz[f]azulen-5-one. Journal of Organic Chemistry 68(19): 7455-7459

Dinolfo, P.H.; Benkstein, K.D.; Stern, C.L.; Hupp, J.T. 2005: C- and Z-shaped coordination compounds. synthesis, structure, and spectroelectrochemistry of cis- and trans-[Re(CO)3(L)]2-2,2'-bisbenzimidizolate with L = 4-phenylpyridine, 2,4'-bipyridine, or pyridine. Inorganic Chemistry 44(24): 8707-8714

Boeckle, S.; Wagner, E.; Ogris, M. 2005: C- versus N-terminally linked melittin-polyethylenimine conjugates: the site of linkage strongly influences activity of DNA polyplexes. Journal of Gene Medicine 7(10): 1335-1347

Roberts, A.; Shah, M.; Chapple, I.L.C. 2003: C-1 esterase inhibitor dysfunction localised to the periodontal tissues: clues to the role of stress in the pathogenesis of chronic periodontitis?. Journal of Clinical Periodontology 30(3): 271-277

Gosek, K.; Moczulski, D.; Zukowska-Szczechowska, E.; Grzeszczak, W. 2005: C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control. NEPHRON. Experimental Nephrology 99(3): E63-E67

Makiishi, T.; Araki, S.-i.; Koya, D.; Maeda, S.; Kashiwagi, A.; Haneda, M. 2003: C-106T polymorphism of AKR1B1 is associated with diabetic nephropathy and erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes mellitus. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 42(5): 943-951

Hain, S.F.; Beggs, A.D. 2004: C-11 methionine uptake in granulomatous disease. Clinical Nuclear Medicine 29(9): 585-586

Goldstein, I.; Pasquier, J.F. 1963: C-14 Fixation by Group a Hemolytic Streptococcus. I. General Conditions of Incorporation of the C-14 Isotope into the Microbial Body. Revue Francaise d'Etudes Cliniques et Biologiques 8: 687-693

Barinova, S.A. 1964: C-14 Incorporation into the Mycelium of Aspergillus Niger Cultivated in Glucose with Na2c-1403. Mikrobiologiia 33: 216-220

Groeschel-Stewart, U.; Turba, F. 1963: C-14 labelling and peptide charts of the SH regions of actomyosin, myosin, actin and H-meromyosin. Biochemische Zeitschrift 337: 104-108

Kalistratov, G.V. 1964: C-14-Beta-Mercaptopropylamine Distribution in Tissues and Organs and its Elimination from Intact and Irradiated Mice. Radiobiologiia 4: 440-444

Beckmann, R. 1963: C-14]). Arzneimittel-Forschung 13: 185-191

Weller, O. 1952: C-17 ketosteroid excretion in liver diseases. Klinische Wochenschrift 30(7-8): 165-167

Eymer, K.P.; Moll, H. 1953: C-17-ketosteroid and corticoid excretion in chronic liver diseases after ACTH administration. Deutsche Medizinische Wochenschrift 78(40): 1376-1377

Eymer, K.P.; Moll, H. 1954: C-17-ketosteroid excretion in acute liver disease after ACTH administration. Arztliche Forschung 8(1): I/38-I/40

Wolff, M.E.; Ho, W. 1964: C-19 Functional Steroids. 7. Desoxycorticosterone-19-Nitrile Acetate. Journal of Medicinal Chemistry 7: 681-682

Wolff, M.E.; Munoz, J.A. 1965: C-19 Functional Steroids. 8. Studies in the Synthesis of the A/B Ring System of Sarmentosigenin e. Journal of Organic Chemistry 30: 920-924

Wolff, M.E.; Morioka, T. 1965: C-19 Functional Steroids. X. 17-Beta-Hydroxy-1-Beta, 19-Cyclo-5-Alpha-Androstan-2-One and Related Compounds. Journal of Organic Chemistry 30: 2553-2557

Wolff, M.E.; Jen, T. 1963: C-19-Functional Steroids. Vi. Testosterone Derivatives. Journal of Medicinal Chemistry 6: 726-732

Uskokovic, M.R.; Manchand, P.; Marczak, S.; Maehr, H.; Jankowski, P.; Adorini, L.; Reddy, G.S. 2006: C-20 cyclopropyl vitamin D3 analogs. Current Topics in Medicinal Chemistry 6(12): 1289-1296

Echigo, S.; Hara, N.; Carderon, G.J.; Duque, C.; Fujimoto, Y. 2006: C-24 stereochemistry of marine sterols: (22E)-24-(isopropenyl)-22-dehydrocholesterol and 24-isopropenylcholesterol. Chemical and Pharmaceutical Bulletin 54(10): 1473-1477

Subramaniyam, D.; Glader, P.; von Wachenfeldt, K.; Burneckiene, J.; Stevens, T.; Janciauskiene, S. 2006: C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. International Journal of Biochemistry and Cell Biology 38(4): 563-575

Freeman, H. 2005: C-ANCA/PR-3 positive colitis may be a distinctive form of inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 41(1): 135

Faugeroux, V.; Génisson, Y.; Andrieu-Abadie, N.; Colié, S.; Levade, T.; Baltas, M. 2006: C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors. Organic and Biomolecular Chemistry 4(24): 4437-4439

Unaldi, S.; Aumann, R.; Fröhlich, R. 2003: C-C alpha insertion: insertion of an alkyne into the C-C single bond between the carbene-carbon atom and the alpha-carbon atom of a Fischer carbene complex by an unprecedented metalla(di-pi-methane) skeletal rearrangement. Chemistry 9(14): 3300-3309

Kurahashi, T.; de Meijere, A. 2005: C-C bond activation by octacarbonyldicobalt: [3+1] cocyclizations of methylenecyclopropanes with carbon monoxide. Angewandte Chemie 44(48): 7881-7884

Lu, T.; Zhuang, X.; Li, Y.; Chen, S. 2004: C-C bond cleavage of acetonitrile by a dinuclear copper(II) cryptate. Journal of the American Chemical Society 126(15): 4760-4761

Sigman, M.; Dehaene, S. 2006: Dynamics of the central bottleneck: dual-task and task uncertainty. Plos Biology 4(7): E220

Bulo, R.E.; Trion, L.; Ehlers, A.W.; de Kanter, F.J.J.; Schakel, M.; Lutz, M.; Spek, A.L.; Lammertsma, K. 2004: C-C bond insertion of a complexed phosphinidene into 1,6-methano[10]annulene. Chemistry 10(21): 5332-5337

Alías, F.M.; Daff, P.J.; Paneque, M.; Poveda, M.L.; Carmona, E.; Pérez, P.J.; Salazar, V.ón.; Alvarado, Y.ía.; Atencio, R.; Sánchez-Delgado, R. 2002: C-C bond-forming reactions of Ir(III)-alkenyls and nitriles or aldehydes: generation of reactive hydride- and alkyl-alkylidene compounds and observation of a reversible 1, 2-H shift in stable hydride-Ir(III) alkylidene complexes. Chemistry 8(22): 5132-5146

Haneline, M.R.; Heyduk, A.F. 2006: C-C bond-forming reductive elimination from a zirconium(IV) redox-active ligand complex. Journal of the American Chemical Society 128(26): 8410-8411

Ying, S. 2000: C-C chemokine expression in atopic and nonatopic asthma. Chemical Immunology 78: 178-188

Trifonov, A.A.; Fedorova, E.A.; Fukin, G.K.; Druzhkov, N.O.; Bochkarev, M.N. 2004: C-C coupling and C-H bond activation-unexpected pathways in the reactions of [Yb(eta5-C13H9)2(thf)2] with diazadienes. Angewandte Chemie 43(38): 5045-5048

Schafer, M.; Wolf, J.; Werner, H. 2005: C-C coupling reactions in the coordination sphere of rhodium(I) and rhodium(III): new routes for the di- and trimerization of terminal alkynes. Dalton Transactions 8: 1468-1481

Gordillo, A.; de Jesús, E.; López-Mardomingo, C. 2006: C-C coupling reactions of aryl bromides and arylsiloxanes in water catalyzed by palladium complexes of phosphanes modified with crown ethers. Organic Letters 8(16): 3517-3520

Zhou, M.; Jiang, L.; Xu, Q. 2004: C-C double- and triple-bond formation from reactions of B atoms with CO: experimental and theoretical characterization of OBBCCO and OBCCBO molecules in solid argon. Chemistry 10(22): 5817-5822

Gandelman, M.; Shimon, L.J.W.; Milstein, D. 2003: C-C versus C-H activation and versus agostic C-C interaction controlled by electron density at the metal center. Chemistry 9(18): 4295-4300

Liu, Y.; Butler, L.J. 2004: C-Cl bond fission dynamics and angular momentum recoupling in the 235 nm photodissociation of allyl chloride. Journal of Chemical Physics 121(22): 11016-11022

Kennedy, J.; Buchan, A.M. 2005: C-EPO: ready for prime-time preconditioning?. Cerebrovascular Diseases 19(4): 272-273; Discussion 273

Burling, S.; Elliott, P.I.P.; Jasim, N.A.; Lindup, R.J.; McKenna, J.; Perutz, R.N.; Archibald, S.J.; Whitwood, A.C. 2005: C-F Bond activation at Ni(0) and simple reactions of square planar Ni(II) fluoride complexes. Dalton Transactions 22: 3686-3695

Liu, C.; Shen, D.-M.; Zeng, Z.; Guo, C.-C.; Chen, Q.-Y. 2006: C-F bond activation by modified sulfinatodehalogenation: facile synthesis and properties of novel tetrafluorobenzoporphyrins by direct intramolecular cyclization and reductive defluorinative aromatization of readily available beta-perfluoroalkylated porphyrins. Journal of Organic Chemistry 71(26): 9772-9783

Noveski, D.; Braun, T.; Neumann, B.; Stammler, A.; Stammler, H.-G. 2004: C-F or C-H bond activation and C-C coupling reactions of fluorinated pyridines at rhodium: synthesis, structure and reactivity of a variety of tetrafluoropyridyl complexes. Dalton Transactions 24: 4106-4119

Augustin, L.A.; Fantini, J.; Mootoo, D.R. 2006: C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120. Bioorganic and Medicinal Chemistry 14(4): 1182-1188

Liu, Y.; Gallagher, T. 2004: C-Glycosides of 2-amino-2-deoxy sugars. beta-C-Glycosides and 1,1-disubstituted variants. Organic Letters 6(14): 2445-2448

Wang, J.; Gardiner, M.G. 2005: C-H Activation (gamma-deprotonation) of a Sm(III) bis(trimethylsilyl)amide complex via macrocyclic stabilisation of the sodium counter ion. Chemical Communications 12: 1589-1591

Paneque, M.; Poveda, M.L.; Carmona, E.; Salazar, V.ón. 2005: C-H Bond activation and C-C bond formation in the reaction of 2,5-dimethylthiophene with TpMe2Ir compounds. Dalton Transactions 8: 1422-1427

Steinke, T.; Cokoja, M.; Gemel, C.; Kempter, A.; Krapp, A.; Frenking, G.; Zenneck, U.; Fischer, R.A. 2005: C-H activated isomers of [M(AlCp*)5] (M=Fe, Ru). Angewandte Chemie 44(19): 2943-2946

Davies, H.M.L.; Manning, J.R. 2006: C-H activation as a strategic reaction: enantioselective synthesis of 4-substituted indoles. Journal of the American Chemical Society 128(4): 1060-1061

Goldsmith, C.R.; Cole, A.P.; Stack, T.D.P. 2005: C-H activation by a mononuclear manganese(III) hydroxide complex: synthesis and characterization of a manganese-lipoxygenase mimic?. Journal of the American Chemical Society 127(27): 9904-9912

Cameron, T.M.; Gordon, J.C.; Scott, B.L.; Tumas, W. 2004: C-H activation of a 2,2[prime or minute]-bipyridine ligand within (mono)pentamethylcyclopentadienyl lutetium complexes. Chemical Communications 12: 1398-1399

Bhalla, G.; Periana, R.A. 2005: C-H activation of alkanes and arenes catalyzed by an O-donor bis(tropolonato)iridium(III) complex. Angewandte Chemie 44(10): 1540-1543

Adlhart, C.; Uggerud, E. 2005: C-H activation of alkanes on Rh+ n (n=1-30) clusters: size effects on dehydrogenation. Journal of Chemical Physics 123(21): 214709

Miller, K.A.; Bartolin, J.M.; O'Neill, R.M.; Sweeder, R.D.; Owens, T.M.; Kampf, J.W.; Banaszak Holl, M.M.; Wells, N.J. 2003: C-H activation of ethers and alkanes by germylene-aryl halide complexes. Journal of the American Chemical Society 125(30): 8986-8987

Duin, M.A.; Clement, N.D.; Cavell, K.J.; Elsevier, C.J. 2003: C-H activation of imidazolium salts by Pt(0) at ambient temperature: synthesis of hydrido platinum bis(carbene) compounds. Chemical Communications 3: 400-401

Burling, S.; Paine, B.M.; Nama, D.; Brown, V.S.; Mahon, M.F.; Prior, T.J.; Pregosin, P.S.; Whittlesey, M.K.; Williams, J.M.J. 2007: C-H activation reactions of ruthenium N-heterocyclic carbene complexes: application in a catalytic tandem reaction involving C-C bond formation from alcohols. Journal of the American Chemical Society 129(7): 1987-1995

Martín, M.; Torres, O.; Oñate, E.; Sola, E.; Oro, L.A. 2005: C-H activations at iridium(I) square-planar complexes promoted by a fifth ligand. Journal of the American Chemical Society 127(51): 18074-18084

Esteruelas, M.A.; Fernandez-Alvarez, F.J.; Olivan, M.; Oñate, E. 2006: C-H bond activation and subsequent C-C bond formation promoted by osmium: 2-vinylpyridine-acetylene couplings. Journal of the American Chemical Society 128(14): 4596-4597

Iverson, C.N.; Carter, C.A.G.; Baker, R.T.; Scollard, J.D.; Labinger, J.A.; Bercaw, J.E. 2003: C-H bond activation by unsymmetrical 2-(N-arylimino)pyrrolide Pt complexes: geometric effects on reactivity. Journal of the American Chemical Society 125(42): 12674-12675

Oulié, P.; Boulho, C.éd.; Vendier, L.; Coppel, Y.; Etienne, M. 2006: C-H bond activation of arenes by a transient eta2-cyclopropene niobium complex. Journal of the American Chemical Society 128(50): 15962-15963

Hoyt, H.M.; Michael, F.E.; Bergman, R.G. 2004: C-H bond activation of hydrocarbons by an imidozirconocene complex. Journal of the American Chemical Society 126(4): 1018-1019

Lu, R.; Gan, W.; Wu, B.-h.; Zhang, Z.; Guo, Y.; Wang, H.-f. 2005: C-H stretching vibrations of methyl, methylene and methine groups at the vapor/alcohol (N = 1-8) interfaces. Journal of Physical Chemistry. B 109(29): 14118-14129

Li, X.; Song, H.; Duan, L.; Cui, C.; Roesky, H.W. 2006: C-H-Activated aluminum hydroxide via molecular oxygen. Inorganic Chemistry 45(5): 1912-1914

Franz, A.H.; Samoshin, V.V.; Myers, C.; Hunter, A.D.; Gross, P.H. 2003: C-H-deprotonation mediated by a remote syn-axial acetoxy group--an unprecedented double bond formation upon cyanation of the dimer from L-fucal. Carbohydrate Research 338(9): 851-854

Rohde, D.; Yan, C.-J.; Wan, L.-J. 2006: C-H...F hydrogen bonding: the origin of the self-assemblies of bis(2,2'-difluoro-1,3,2-dioxaborine). Langmuir 22(10): 4750-4757

Domagała, M.łg.; Grabowski, S.ła.J. 2005: C-H...N and C-H...S hydrogen bonds--influence of hybridization on their strength. Journal of Physical Chemistry. a 109(25): 5683-5688

Coruh, U.; Kahveci, B.; Saşmaz, S.; Agar, E.; Kim, Y.; Erdönmez, A. 2003: C-H...O and C-H...pi interactions in 1-acetyl-4-(p-chlorobenzylideneamino)-3-ethyl-4,5-dihydro-1H-1,2,4-triazol-5-one. Acta Crystallographica. Section C Crystal Structure Communications 59(Part 8): O476-O478

Desiraju, G.R. 2005: C-H...O and other weak hydrogen bonds. from crystal engineering to virtual screening. Chemical Communications 24: 2995-3001

Liu, G.; Ping, L.; Li, H. 2007: C-H...O hydrogen bond in chloroform-triformylmethane complex: blue-shifted or red-shifted?. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 66(3): 643-645

Vaz, P.D.; Nolasco, M.; Fonseca, N.; Amado, A.M.; Costa, A.ón.M.A.d.; Félix, V.; Drew, M.G.B.; Goodfellow, B.J.; Ribeiro-Claro, P.J.A. 2005: C-H...O hydrogen bonding in 4-phenyl-benzaldehyde: a comprehensive crystallographic, spectroscopic and computational study. Physical Chemistry Chemical Physics: Pccp 7(16): 3027-3034

Nolasco, M.M.; Ribeiro-Claro, P.J.A. 2005: C-H...O hydrogen bonds in cyclohexenone reveal the spectroscopic behavior of Csp3-H and Csp2-H donors. Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry 6(3): 496-502

Yilmaz, V.T.; Kazak, C.; Kirilmis, C.; Koca, M.; Heinemann, F.W. 2005: C-H...O, C-H...pi and pi-pi interactions in three benzofuran-2-yl ketone derivatives. Acta Crystallographica. Section C Crystal Structure Communications 61(Part 7): O438-O441

Medaković, V.B.; Milcić, M.K.; Bogdanović, G.A.; Zarić, S.D. 2004: C-H...pi interactions in the metal-porphyrin complexes with chelate ring as the H acceptor. Journal of Inorganic Biochemistry 98(11): 1867-1873

You, X.-L.; Lu, C.-R.; Zhang, Y.; Zhang, D.-C. 2004: C-H...pi, pi-pi and C-H...Cl interactions in chloro-substituted Schiff bases and 4-chloro-N-[4-(dimethylamino)benzylidene]aniline. Acta Crystallographica. Section C Crystal Structure Communications 60(Part 9): O693-O695

Pawate, S.; Bhat, N.R. 2006: C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform. Antioxidants and Redox Signaling 8(5-6): 903-909

Yu, W.; Fraser, R.B.; Gaskin, D.A.; Fernandez, C.V.; Wright, J.R. 2005: C-Kit-positive metastatic malignant pigmented clear-cell epithelioid tumor arising from the kidney in a child without tuberous sclerosis. Annals of Diagnostic Pathology 9(6): 330-334

Clark, E.W.; Morishita, F. 1950: C-M medium; a mounting medium for small insects, mites, and other whole mounts. Science 112(2922): 789-790

Rasmussen, T.; Knudsen, L.Meldgaard.; Dahl, I.Marie.S.; Johnsen, H.Erik. 2003: C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance. Leukemia and Lymphoma 44(10): 1761-1766

Assisi, D.; Grassi, A.; La Penta, R.; Stigliano, V.; Greco, C.; Cianciulli, A.M.; Giannarelli, D.; Casale, V. 2004: C-MYB, serum P-53M, genetic instability, labeling index and endoscopic findings in patients with adenoma or colorectal cancer. Journal of Experimental and Clinical Cancer Research: Cr 23(3): 469-475

Burbano, R.R.íg.; Assumpção, P.P.; Leal, M.F.; Calcagno, D.Q.; Guimarães, A.C.; Khayat, A.é S.; Takeno, S.S.; Chen, E.S.; De Arruda Cardoso Smith, M.íl. 2006: C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Research 26(4b): 2909-2914

Akesson, C.; Pero, R.W.; Ivars, F. 2003: C-Med 100, a hot water extract of Uncaria tomentosa, prolongs lymphocyte survival in vivo. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 10(1): 23-33

Cai, X.; Sakamoto, M.; Yamaji, M.; Fujitsuka, M.; Majima, T. 2005: C-O bond cleavage of benzophenone substituted by 4-CH2OR (R = C6H5 and CH3) with stepwise two-photon excitation. Journal of Physical Chemistry. a 109(27): 5989-5994

Sundararajan, C.; Falvey, D.E. 2004: C-O bond fragmentation of 4-picolyl- and N-methyl-4-picolinium esters triggered by photochemical electron transfer. Journal of Organic Chemistry 69(17): 5547-5554

Yudanov, I.V.; Neyman, K.M.; Rösch, N. 2006: C-O bond scission of methoxide on Pd nanoparticles: a density functional study. Physical Chemistry Chemical Physics: Pccp 8(20): 2396-2401

Cai, X.; Sakamoto, M.; Yamaji, M.; Fujitsuka, M.; Majima, T. 2007: C-O-bond cleavage of esters with a naphthyl group in the higher triplet excited state during two-color two-laser flash photolysis. Chemistry 13(11): 3143-3149

Bell, D.S.; Ovalle, F. 1999: C-Peptide utilization in clinical practice: effect on treatment and outcome of diabetes in a series of cases. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 5(3): 114-118

Koch, K.E.; Schrader, L.E. 1984: C-Photosynthate Partitioning and Translocation in Soybeans during Reproductive Development. Plant Physiology 75(4): 1040-1043

Anonymous 1956: C-REACTIVE protein. British Medical Journal 2(4985): 145-146

Anonymous 1954: C-REACTIVE protein in acute rheumatic fever. Journal of the Medical Association of Georgia 43(11): 925

Gupta, A.K.; Bernhard, E.J.; Bakanauskas, V.J.; Cerniglia, G.J.; Muschel, R.J.; McKenna, G. 2003: C-Raf-1 protein kinase is not essential for Ras transformation of mouse embryo fibroblasts. Cancer Biology and Therapy 2(1): 73-75

Vannuci, N. 1964: C-Reactive Blood Protein and Neoplasms of Various Localizations and Histogenesis. Archivio italiano di chirurgia 90: 84-92

Slugenova, E. 1964: C-Reactive Protein. Lekarsky Obzor 13: 35-43

Lapszewicz, A. 1964: C-Reactive Protein (Crp) in the Cerebrospinal Fluid. Postepy Higieny i Medycyny Doswiadczalnej 18: 257-265

Capezzuto, A.; Germano, D. 1964: C-Reactive Protein in Allergic Skin Diseases Due to Cement Dust. Folia Medica. Folia Medica 47: 1166-1169

Saiko, A.A. 1964: C-Reactive Protein in Brain Tumors. Voprosy Neirokhirurgii 28: 21-23

Canales, L. 1964: C-Reactive Protein in Children with Heart Diseases. Clinica y Laboratorio 78: 21-29

Barua, D.; Sack, B. 1963: C-Reactive Protein in Cholera: a Preliminary Report. Bulletin of the Calcutta School of Tropical Medicine 11: 86-87

Dobrotina, N.A. 1963: C-Reactive Protein in different Dermatoses. Vestnik Dermatologii i Venerologii 37: 9-13

Gutierrezbarneto, G. 1963: C-Reactive Protein in Infancy. Acta Pediatrica Espanola 21: 655-660

Reznikova, L.S.; Trofimova, L.I. 1963: C-Reactive Protein in Lupus Erythematosus and other Dermatoses. Vestnik Dermatologii i Venerologii 37: 3-9

Medvedeva, A.F. 1965: C-Reactive Protein in Odontogenous Osteomyelitis. Stomatologiia 44: 54-57

Defeo, V. 1965: C-Reactive Protein in Pathology of Childhood. I. Biochemical and Immunologic Aspects. Bollettino Dell'istituto Sieroterapico Milanese 44: 125-148

Budanova, L.F.; Danilova, T.N. 1965: C-Reactive Protein in the Blood Serum in some Occupational Diseases. Terapevticheskii Arkhiv 37: 102-104

Cavalli, D. 1964: C-Reactive Protein in Threatened Abortion, Abortion in Progress and Internal Abortion. Quaderni di Clinica Ostetrica e Ginecologica 19: 107-114

Mukhin, V.F.; Markelov, I.M. 1964: C-Reactive Protein test and State of the Protein Fractions in the Blood Serum in Burns (Clinico-Laboratory Comparison). Laboratornoe Delo 10: 407-410

Goldenberg, I.S. 1964: C-Reactive Protein test as an Indication of Patient's Condition in some Skin Diseases. Vestnik Dermatologii i Venerologii 38: 27-31

Lubashevskaia, L.N. 1964: C-Reactive Protein test in Dermatological Clinical Practice. Vestnik Dermatologii i Venerologii 38: 22-27

Duray, A.; Stuber, A. 1963: C-Reactive Protein tests in Laryngeal Diseases. Ful- Orr- Gegegyogyazat 9: 166-169

Djamchidi, A.A. 1964: C-Reactive Protein, Antistreptolysin Titer and Waller-Rose test as well as Blood Sedimentation and Blood Picture in relation to Otorhinolaryngological Operations for the Purpose of Elimination of Focal Infection. Deutsches Medizinisches Journal 15: 6-9

Pianese, G.; Laurenza, A. 1960: C-Reactive protein and antidiphtheric anatoxin vaccination. Rivista Dell'istituto Sieroterapico Italiano 35: 509-514

Raevskaia, G.A. 1961: C-Reactive protein and fibrinogen in the blood in patients with myocardial infarct. Sovetskaia Meditsina 25: 16-22

Ramlawi, B.; Rudolph, J.L.; Mieno, S.; Feng, J.; Boodhwani, M.; Khabbaz, K.; Levkoff, S.E.; Marcantonio, E.R.; Bianchi, C.; Sellke, F.W. 2006: C-Reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Surgery 140(2): 221-226

Zhang, L.; Kao, W.H.L.; Berthier-Schaad, Y.; Plantinga, L.; Fink, N.; Smith, M.W.; Coresh, J. 2007: C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 49(1): 118-126

Alaedeen, D.I.; Queen, A.L.; Leung, E.; Liu, D.; Chwals, W.J. 2004: C-Reactive protein-determined injury severity: length of stay predictor in surgical infants. Journal of Pediatric Surgery 39(12): 1832-1834

Titov, V.N. 2003: C-Reactive protein. Activation of inflammation by intensifying absorption of fatty acids by cells of the friable connective tissue. Klinicheskaia Laboratornaia Diagnostika 7: 3-9

Lozovan, M.G. 1964: C-Reative Protein as a Criterion of Activity of Pulmonary Tuberculosis. Problemy Tuberkuleza 42: 34-37

Huguet, C.; Enrietto, P.; Vandenbunder, B.; Abbadie, C. 1994: C-Rel: a multifunctional transcription factor ?. Cell Death and Differentiation 1(2): 71-76

Badawi, H.M. 2004: C-S barrier and vibrational analyses of (halocarbonyl)sulfenyl halides XCO-SX (X = F, Cl, and Br). Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 60(11): 2573-2580

Osako, T.; Ueno, Y.; Tachi, Y.; Itoh, S. 2004: C-S bond formation reaction between a phenolate and disulfide-bridged dicopper(I) complexes. Inorganic Chemistry 43(21): 6516-6518

Wojahn, H. 1952: C-S compounds. V. Quantitative determination of thioamides and dithiocarbaminote derivatives. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 22(8): 375-382

Dick, T. 2007: C-Spine on the side. more stuff you can do with a blanket. Jems: a Journal of Emergency Medical Services 32(2): 28

Aberg, V.; Hedenström, M.; Pinkner, J.S.; Hultgren, S.J.; Almqvist, F. 2005: C-Terminal properties are important for ring-fused 2-pyridones that interfere with the chaperone function in uropathogenic E. coli. Organic and Biomolecular Chemistry 3(21): 3886-3892

Huegin, W.; Kissling, P. 1961: C-Toxiferin i in clinical anesthesia. Der Anaesthesist 10: 137-139

El-Dahshan, A.; Weik, S.; Rademann, J.ör. 2007: C-acylations of polymeric phosphoranylidene acetates for C-terminal variation of peptide carboxylic acids. Organic Letters 9(6): 949-952

Shore, B. 1957: C-and N-terminal amino acids of human serum lipoproteins. Archives of Biochemistry and Biophysics 71(1): 1-10

Grützner, P.A.; Zheng, G.; Langlotz, U.; von Recum, J.; Nolte, L.P.; Wentzensen, A.; Widmer, K.-H.; Wendl, K. 2004: C-arm based navigation in total hip arthroplasty-background and clinical experience. Injury 35(Suppl 1): S

Jain, A.; Kon, R.; Zhou, Y.; Fichtinger, G. 2005: C-arm calibration--is it really necessary?. Medical Image Computing and Computer-Assisted Intervention: Miccai . International Conference on Medical Image Computing and Computer-Assisted Intervention 8(Part 1): 639-646

Jain, A.; Fichtinger, G. 2006: C-arm tracking and reconstruction without an external tracker. Medical Image Computing and Computer-Assisted Intervention: Miccai . International Conference on Medical Image Computing and Computer-Assisted Intervention 9(Part 1): 494-502

Wirth, S.; Euler, E.; Linsenmaier, U.; Heining, S.-M.; Kotsianos, D.; Pfeifer, K.-J.ür.; Mutschler, W.; Reiser, M. 2004: C-arm-based mobile computed tomography: a comparison with established imaging on the basis of simulated treatments of talus neck fractures in a cadaveric study. Computer Aided Surgery: Official Journal of the International Society for Computer Aided Surgery 9(1-2): 27-38

Euler, E.; Heining, S.; Riquarts, C.; Mutschler, W. 2003: C-arm-based three-dimensional navigation: a preliminary feasibility study. Computer Aided Surgery: Official Journal of the International Society for Computer Aided Surgery 8(1): 35-41

Choi, S.-S.; Lee, P.-B.; Kim, Y.-C.; Kim, H.-J.; Lee, S.-C. 2006: C-arm-guided pudendal nerve block: a new technique. International Journal of Clinical Practice 60(5): 553-556

Rozek, M.; Lachowska, D. 2003: C-banded chromosomes of the genus Bembidion Latr. (Coleoptera, Carabidae). Folia Biologica 51(3-4): 143-146

Fuhrmann, G.; Debaerdemaeker, T.; Bäuerle, P. 2003: C-c bond formation through oxidatively induced elimination of platinum complexes--a novel approach towards conjugated macrocycles. Chemical Communications 8: 948-949

Lima, M.A.; Tiveron, F.S.; Santos, V.M.; Lima, L.M.B.; Silva, G.P.; Borges, M.F. 2003: C-cells in colloid goiter. Revista do Hospital das Clinicas 58(6): 310-314

Titova, M.A.; Saleeva, G.T.; Valeeva, I.K.; Orlov, S.B.; Kiiasov, A.P. 2003: C-cells of the thyroid gland in experimental osteoporosis. Morfologiia 123(2): 68-72

Yoshida, S.; Nakagomi, K.; Goto, S.; Futatsubashi, M.; Torizuka, T. 2006: C-choline positron emission tomography in bladder cancer: report of four cases. International Journal of Urology: Official Journal of the Japanese Urological Association 13(6): 829-831

Leonardo, C.; Merola, R.; Orlandi, G.; Leonardo, F.; Rondoni, M.; De Nunzio, C. 2005: C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results. Journal of Experimental and Clinical Cancer Research: Cr 24(4): 633-638

Barwijuk-Machała, M.; Reszeć, J.; Kemona, A.; Sobaniec-Lotowska, M. 2004: C-erb-B2 and Bcl-xl protein expression in Barrett's oesophagus in correlation with morphological parameters. Roczniki Akademii Medycznej W Bialymstoku 49(Suppl 1): 40-42

Roşian, A.; Lazăr, E.; Dema, A. 2005: C-erbB2 oncoprotein: prognostic marker in breast cancer. Romanian Journal of Morphology and Embryology 46(2): 99-104

Carley, D.W.; Pavlovic, S.; Malis, M.; Knezevic, N.; Saponjic, J.; Li, C.; Radulovacki, M. 2004: C-fiber activation exacerbates sleep-disordered breathing in rats. Sleep and Breathing 8(3): 147-154

Magdalena, C.M.; Navarro, V.P.; Park, D.M.; Stuani, M.B.S.; Rocha, M.J.A. 2004: C-fos expression in rat brain nuclei following incisor tooth movement. Journal of Dental Research 83(1): 50-54

Takaoki, M.; Murakami, N.; Gyotoku, J.-I. 2004: C-fos expression of osteoblast-like MC3T3-E1 cells induced either by cooling or by fluid flow. Uchu Seibutsu Kagaku 18(3): 181-182

Novikova, N.S.; Kazakova, T.B.; Rogers, V.; Korneva, E.A. 2002: C-fos gene expression in the rat spinal cord and brain cells during stress and the use of different types of halothane anesthesia. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 88(11): 1378-1387

Zvorykina, S.V.; Anokhin, K.V. 2003: C-fos topography in neocortical neurons of mice during fear conditioning. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 53(4): 518-522

Dondoni, A.; Marra, A. 2006: C-glycoside clustering on calix[4]arene, adamantane, and benzene scaffolds through 1,2,3-triazole linkers. Journal of Organic Chemistry 71(20): 7546-7557

Tóth, M.; Kövér, K.E.; Bényei, A.; Somsák, L.ás.ó 2003: C-glycosylmethylene carbenes: synthesis of anhydro-aldose tosylhydrazones as precursors; generation and a new synthetic route to exo-glycals. Organic and Biomolecular Chemistry 1(22): 4039-4046

Nagaraj, B.; Narasimhamurthy, T.; Yathirajan, H.S.; Nagaraja, P.; Narasegowda, R.S.; Rathore, R.S. 2005: C-halogen...pi dimer and C-H...pi interactions in 1-(2-bromo-4,5-dimethoxybenzyl)-2-butyl-4-chloro-1H-imidazole-5-carbaldehyde and 2-butyl-4-chloro-1-(6-methyl-1,3-benzodioxol-5-ylmethyl)-1H-imidazole-5-carbaldehyde. Acta Crystallographica. Section C Crystal Structure Communications 61(Part 3): O177-O180

Chulkov, P.S. 1950: C-hypovitaminosis in chronic dysentery and its pathogenetic importance. Terapevticheskii Arkhiv 22(3): 80-84

Advani, A.S. 2005: C-kit as a target in the treatment of acute myelogenous leukemia. Current Hematology Reports 4(1): 51-58

Nakamura, H.; Takeshima, H.; Makino, K.; Kuratsu, J.-I. 2005: C-kit expression in germinoma: an immunohistochemistry-based study. Journal of Neuro-Oncology 75(2): 163-167

Goldstein, N.S. 2003: C-kit expression in small cell lung carcinomas. Human Pathology 34(8): 827; Author Reply 828

Hou, Y.-Y.; Tan, Y.-S.; Sun, M.-H.; Wei, Y.-K.; Xu, J.-F.; Lu, S.-H.; A-Ke-Su, S.-J.; Zhou, Y.-N.; Gao, F.; Zheng, A.-H.; Zhang, T.-M.; Hou, W.-Z.; Wang, J.; Du, X.; Zhu, X.-Z. 2004: C-kit gene mutation in human gastrointestinal stromal tumors. World Journal of Gastroenterology 10(9): 1310-1314

Morini, M.; Bettini, G.; Preziosi, R.; Mandrioli, L. 2004: C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 52(5): 705-708

Ciontea, S.M.; Radu, E.; Regalia, T.; Ceafalan, L.; Cretoiu, D.; Gherghiceanu, M.; Braga, R.I.; Malincenco, M.; Zagrean, L.; Hinescu, M.E.; Popescu, L.M. 2005: C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. Journal of Cellular and Molecular Medicine 9(2): 407-420

Arena, F.; Nicòtina, P.A.; Arena, S.; Romeo, C.; Zuccarello, B.; Romeo, G. 2007: C-kit positive interstitial cells of Cajal network in primary obstructive megaureter. Minerva Pediatrica 59(1): 7-11

Kraj, M.; Pogłód, R.; Kopeć-Szlezak, J.; Sokołowska, U.; Woźniak, J.; Kruk, B. 2004: C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies. Leukemia and Lymphoma 45(11): 2281-2289

Scotlandi, K.; Manara, M.C.; Strammiello, R.; Landuzzi, L.; Benini, S.; Perdichizzi, S.; Serra, M.; Astolfi, A.; Nicoletti, G.; Lollini, P.-L.; Bertoni, F.; Nanni, P.; Picci, P. 2003: C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(10): 1952-1960

Tsao, A.S.; Kantarjian, H.; Thomas, D.; Giles, F.; Cortes, J.; Garcia-Manero, G.; Huh, Y.; Yang, Y.; Shen, Y.; Albitar, M.; Estey, E. 2004: C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Leukemia Research 28(4): 373-378

Awad, L.; Riedner, J.; Vogel, P. 2005: C-linked disaccharide analogue of the Thomsen-Friedenreich (T)-epitope alpha-O-conjugated to L-serine. Chemistry 11(12): 3565-3573

Liu, S.; Ben, R.N. 2005: C-linked galactosyl serine AFGP analogues as potent recrystallization inhibitors. Organic Letters 7(12): 2385-2388

Fleming, F.F.; Zhang, Z.; Wei, G.; Steward, O.W. 2006: C-metalated nitriles: electrophile-dependent alkylations and acylations. Journal of Organic Chemistry 71(4): 1430-1435

Carpentier, S.; Fromageot, C. 1950: C-mitotic activity of the gamma-isomer and of the delta-hexachlorocyclohexane, with reference to the influence of mesoinositol and sodium inositophosphate. Biochimica et Biophysica Acta 5(2): 290-296

Stetten, G.; Cois, A.; Chang, W.; Shelton, D.; Tamburo, R.; Castellucci, J.; von Ramm, O. 2005: C-mode real-time tomographic reflection for a matrix array ultrasound sonic flashlight. Academic Radiology 12(5): 535-543

Schlee, M.; Hölzel, M.; Bernard, S.; Mailhammer, R.; Schuhmacher, M.; Reschke, J.; Eick, D.; Marinkovic, D.; Wirth, T.; Rosenwald, A.; Staudt, L.M.; Eilers, M.; Baran-Marszak, F.; Fagard, R.; Feuillard, J.; Laux, G.; Bornkamm, G.W. 2007: C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma. International Journal of Cancer 120(7): 1387-1395

Gómez-Casares, M.T.; Vaqué, J.P.; Lemes, A.; Molero, T.; Delgado, M.D.; León, J. 2004: C-myc expression in cell lines derived from chronic myeloid leukemia. Haematologica 89(2): 241-243

Schlotter, C.M.; Vogt, U.; Bosse, U.; Mersch, B.; Wassmann, K. 2003: C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer. Breast Cancer Research: Bcr 5(2): R30-R36

Chung, K.; Kim, S-Hun.; Kook, Y. 2005: C-orthodontic microimplant for distalization of mandibular dentition in Class III correction. Angle Orthodontist 75(1): 119-128

Aakeröy, C.B.; Schultheiss, N.; Desper, J. 2006: C-pentyltetra(3-pyridyl)cavitand: a versatile building block for the directed assembly of hydrogen-bonded heterodimeric capsules. Organic Letters 8(12): 2607-2610

Carina Törn 2003: C-peptide and Autoimmune Markers in Diabetes. Clinical Laboratory 49(1-2): 1-10

Li, Z-Guo.; Sima, A.A.F. 2004: C-peptide and central nervous system complications in diabetes. Experimental Diabesity Research 5(1): 79-90

Sima, A.A.F. 2003: C-peptide and diabetic neuropathy. Expert Opinion on Investigational Drugs 12(9): 1471-1488

Chakrabarti, S.; Khan, Z.Ali.; Cukiernik, M.; Zhang, W.; Sima, A.A.E. 2004: C-peptide and retinal microangiopathy in diabetes. Experimental Diabesity Research 5(1): 91-96

Johansson, B.-L.; Sundell, J.; Ekberg, K.; Jonsson, C.; Seppänen, M.; Raitakari, O.; Luotolahti, M.; Nuutila, P.; Wahren, J.; Knuuti, J. 2004: C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. American Journal of Physiology. Endocrinology and Metabolism 286(1): E14-E19

Palmer, J.P.; Fleming, G.Alexander.; Greenbaum, C.J.; Herold, K.C.; Jansa, L.D.; Kolb, H.; Lachin, J.M.; Polonsky, K.S.; Pozzilli, P.; Skyler, J.S.; Steffes, M.W. 2004: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53(1): 250-264

Al-Rasheed, N.M.; Willars, G.B.; Brunskill, N.J. 2006: C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. Journal of the American Society of Nephrology: Jasn 17(4): 986-995

Vague, P.; Coste, T.C.; Jannot, M.F.; Raccah, D.; Tsimaratos, M. 2004: C-peptide, Na+,K(+)-ATPase, and diabetes. Experimental Diabesity Research 5(1): 37-50

Wahren, J.; Ekberg, K.; Samnegård, B.; Johansson, B.L. 2001: C-peptide: a new potential in the treatment of diabetic nephropathy. Current Diabetes Reports 1(3): 261-266

Reale, L. 1957: C-protein test in silicosis and pulmonary silicotuberculosis. Rassegna di Fisiopatologia Clinica e Terapeutica 29(9): 1008-1018

Ruggieri, P.A. 1955: C-reactive blood protein in inflammatory disease; its value as an index of rheumatic activity. Journal of the Medical Society of New Jersey 52(10): 500-504

Genesi, M. 1957: C-reactive blood proteins in biology & clinical practice. Minerva Medica 48(78): 3146-3152

Zina, G.; Bonu, G. 1957: C-reactive protein and phlogogram in certain dermatoses. Minerva Dermatologica 32(11): 405-415

D'Aiuto, F.; Casas, J.P.; Shah, T.; Humphries, S.E.; Hingorani, A.D.; Tonetti, M.S. 2005: C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179(2): 413-417

Szalai, A.J. 2004: C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clinical and Developmental Immunology 11(3-4): 221-226

Abdellaoui, A.; Al-Khaffaf, H. 2007: C-reactive protein (CRP) as a marker in peripheral vascular disease. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 34(1): 18-22

Gupta, R.; Singh, R.; Soni, M. 2002: C-reactive protein (CRP) as an indicator of sepsis in orthopaedic trauma. Indian Journal of Medical Sciences 56(10): 501-507

Bonelli, M.; Armuzzi, G.; Tomasini, C. 1962: C-reactive protein (CRP) in syphilitic infection. Giornale Italiano di Dermatologia 103: 199-204

Prasad, K. 2006: C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews 24(1): 33-50

Vormittag, R.; Funk, M.; Mannhalter, C.; Schönauer, V.; Vukovich, T.; Minar, E.; Bialonczyk, C.; Hirschl, M.; Pabinger, I. 2006: C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism. Atherosclerosis 188(2): 406-411

Liang, Y.-J.; Shyu, K.-G.; Wang, B.-W.; Lai, L.-P. 2006: C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. Journal of Molecular and Cellular Cardiology 40(3): 412-420

Verma, S.; Badiwala, M.V.; Weisel, R.D.; Li, S.-H.; Wang, C.-H.; Fedak, P.W.M.; Li, R.-K.; Mickle, D.A.G. 2003: C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. Journal of Thoracic and Cardiovascular Surgery 126(6): 1886-1891

Salvati, F.; Gulotta, G.; Serra, B. 1960: C-reactive protein after exeresis and pleuropulmonary decortication for tuberculosis. Annali Dell'istituto "carlo Forlanini" 20: 538-548

Conen, D.; Dieterle, T.; Utech, K.; Rimner, M.; Martina, B. 2006: C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives. Hypertension Research: Official Journal of the Japanese Society of Hypertension 29(6): 411-415

Herron, D.M. 2005: C-reactive protein and adiposity: obesity as a systemic inflammatory state. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 1(3): 385-386

Balcells-Gorina, A.; Alvarez, M.A. 1958: C-reactive protein and agammaglobulinemia. Revista Clinica Espanola 69(6): 376-377

Averina, M.; Nilssen, O.; Arkhipovsky, V.L.; Kalinin, A.G.; Brox, J. 2006: C-reactive protein and alcohol consumption: Is there a U-shaped association? Results from a population-based study in Russia. The Arkhangelsk study. Atherosclerosis 188(2): 309-315

Chodorowska, G.; Wojnowska, D.; Juszkiewicz-Borowiec, M. 2004: C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. Journal of the European Academy of Dermatology and Venereology: Jeadv 18(2): 180-183

Breiterman-White, R. 2006: C-reactive protein and anemia: implications for patients on dialysis. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 33(5): 555-558

Paniagua, R.ón.; Frías, Y.; de Ventura, M.J.ús.; Rodríguez, E.; Hurtado, M.ía.E.; Alcántara, G.; Vázquez, R.; Ortiz, R.; Salcedo, M.; Rios, M.E.; Kaji, J.; Amato, D. 2003: C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(2): 132-137

Kosar, F.; Aksoy, Y.ük.; Ozguntekin, G.; Yetkin, E.; Gunen, H. 2007: C-reactive protein and aortic stiffness in patients with idiopathic dilated cardiomyopathy. Echocardiography 24(1): 1-8

Verma, S.; Yeh, E.T.H. 2003: C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 285(5): R1253

Hernández Madrid, A. 2006: C-reactive protein and atrial fibrillation. An old marker looking for a new target. Revista Espanola de Cardiologia 59(2): 94-98

Di Napoli, M.; Papa, F. 2003: C-reactive protein and blood pressure in the acute phase after an ischemic stroke. Stroke 34(4): 839

Kilic-Okman, T.; Kucuk, M.; Ekuklu, G. 2004: C-reactive protein and body mass index in women with pre-eclampsia. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 84(1): 75-76

Williams, M.J.A.; Milne, B.J.; Hancox, R.J.; Poulton, R. 2005: C-reactive protein and cardiorespiratory fitness in young adults. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 12(3): 216-220

Xu, Y.; Whitmer, K. 2006: C-reactive protein and cardiovascular disease in people with diabetes: high-sensitivity CRP testing can help assess risk for future cardiovascular disease events in this population. American Journal of Nursing 106(8): 66-72

Davey Smith, G.; Timpson, N.; Lawlor, D.A. 2006: C-reactive protein and cardiovascular disease risk: still an unknown quantity?. Annals of Internal Medicine 145(1): 70-72

Santos, W.B.; Mesquita, E.T.; Vieira, R.M.R.; Olej, B.; Coutinho, M.ár.; Avezum, A. 2003: C-reactive protein and cardiovascular disease. Basis of scientific evidence. Arquivos Brasileiros de Cardiologia 80(4): 452-456

Sepulveda, J.L.; Mehta, J.L. 2005: C-reactive protein and cardiovascular disease: a critical appraisal. Current Opinion in Cardiology 20(5): 407-416

Hashimoto, J.; O'Rourke, M.F. 2006: C-reactive protein and cardiovascular disease: are we looking in the right direction?. Journal of Hypertension 24(10): 2115

Lowe, G.D.O.; Pepys, M.B. 2006: C-reactive protein and cardiovascular disease: weighing the evidence. Current Atherosclerosis Reports 8(5): 421-428

Ridker, P.; Rifai, N.; Koenig, W.; Blumenthal, R.S. 2006: C-reactive protein and cardiovascular risk in the Framingham Study. Archives of Internal Medicine 166(12): 1327-1328; Author Reply 1328

Di Napoli, M.; Papa, F. 2005: C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology?. Circulation 112(6): 781-785

Shucard, J.L.; Gaines, J.J.; Ambrus, J.; Shucard, D.W. 2007: C-reactive protein and cognitive deficits in systemic lupus erythematosus. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology 20(1): 31-37

Mazhar, D.; Ngan, S. 2006: C-reactive protein and colorectal cancer. Qjm: Monthly Journal of the Association of Physicians 99(8): 555-559

Ridker, P.M.; Koenig, W.; Fuster, V. 2004: C-reactive protein and coronary heart disease. New England Journal of Medicine 351(3): 295-298; Author Reply 295-298

Corwin, E.J.; Klein, L.C. 2003: C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence. Human Psychopharmacology 18(5): 329-337

Hecht, H.; Rumberger, J.A.; Budoff, M.J. 2003: C-reactive protein and electron beam tomography. Circulation 107(18): E123

Lacson, E.; Levin, N.W. 2004: C-reactive protein and end-stage renal disease. Seminars in Dialysis 17(6): 438-448

Estrores, I.M.; Harrington, A.; Banovac, K. 2004: C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury. Journal of Spinal Cord Medicine 27(5): 434-437

Sonnet, J.; Michaux, J.L. 1960: C-reactive protein and gamma x-globulin in Bantus of the Lower Congo. Clinica Chimica Acta; International Journal of Clinical Chemistry 5: 223-229

King, D.E.; Mainous, A.G.; Buchanan, T.A.; Pearson, W.S. 2003: C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26(5): 1535-1539